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  ABSTRACT 
 Crustacean processing in Louisiana generates vast amounts of byproducts, including 
crawfish processing byproducts (CB), whose disposal can be problematic unless utilized 
alternatively. The objective of this investigation was to design and develop a delivery system 
(DS) containing extracted astaxanthin (AX) from CB using a novel combined ethanol flaxseed 
oil (FO) ultrasound assisted extraction (UAE) method and evaluate its quality characteristics. 
Additionally, anticancer effects of AX were evaluated. Investigations consisted of three studies. 
Proximate composition, oxidative stability, and antioxidant capacity of AX from CB 
extracted both conventionally and by UAE was determined. AX concentration conventionally 
extracted from CB (FOCAX) was 0.0919 mg g−1 of FO. The combined UAE ethanol FO 
extracted AX from CB (FOCAXUAE) was 1.9 mg g−1 of FO with antioxidant capacity 
(71.81±0.42) significantly greater than FOCAX (63.16±0.22). FOCAXUAE was selected for use 
in further studies.  
A pectin gelatin DSs (PGDS) for controlled release of extracted AX was developed. 
Releasing profiles of several formulations containing high degrees of methylation (HMP) or low 
degrees of methylation (LMP) pectins were evaluated. The in vitro release study investigated 
release of AX in simulated gastric fluid (SGF) and simulated intestinal fluid (SIF). However, 
desired release characteristics were obtained with the addition of hydroxypropyl methylcellulose 
(HPMC). Swelling index of both HMP and LMP formulations with HPMC in SIF after 180 
minutes were 126.46% and 90.61%, respectively. Other formulations failed to swell in SIF, with 
exposure to low pH SGF resulting in all formulations rapidly releasing FOCAXUAE.  
Anticancer properties were considered. A control (sunflower lecithin and FO in DMEM, 
Dulbecco’s modified Eagles medium) in the ratio (0.0025:0.005:1) on the viability of MDA-MB-
 xvi 
231 cell lines showed RCV (relative cell viability) of 79.37±0.87 % (RCV of 97.37±0.06%, 
normalized to DMEM alone). RCV of MDA-MB-231 cells treated with AX (3µM, 5µM, and 7 
µM) had significantly decreased (46.31±0.81%, 42.2±0.65%, and 55.51±0.19%, respectively).  
Cell densities decreased in some groups treated with AX, showing fewer cells with 
mesenchymal-like shapes, suggesting reversal of the epithelial-to-mesenchymal transition 
(EMT). This research indicates high amounts of AX extracted from CB by UAE has cytotoxic 
activity that could be incorporated into polymer-based DS.   
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CHAPTER 1 LITERATURE REVIEW 
 
1.1 Louisiana seafood 
The State of Louisiana is known as the “Sportsman’s Paradise” due to its beautiful landscape 
for hunting and waters for fishing, that attract tourist from around the world. In addition to the 
thrill or hunting and fishing, there are a plethora of restaurants throughout Louisiana that serve 
up that delicious food that many people long to experience. From an economic standpoint, 
Louisiana seafood industry generates almost $2 billion in sales annually, while supporting over 
33,000 jobs, not including recreational fishing (Gaudé, 2019).  
1.1.1 Red swamp crawfish (Procambarus clarkii) 
In 1983 the red swamp crawfish (Procambarus clarkii) Louisiana crawfish, was 
designated as the state's crustacean (Schedler, 2011). In North America, Louisiana dominates the 
crawfish industry, accounting for about 90%-95% of the total production in the United States. 
Crawfish are an important commercial species cultured with high market values exceeding $170 
million annually (Osti, Bampasidou, & Fannin, 2018). In the southern region of the United States 
crawfish are regarded more communally and have had a greater impact economically than any 
other place where they exist in the world. In addition to the edible portions of crawfish, several 
other components can be derived from crawfish byproducts like flavor compounds, chitin, 
chitosan and carotenoids like astaxanthin (Meyers & Bligh, 1981; Hong K No & Meyers, 1989; 
Hong K No, Meyers, & Lee, 1989; Tanchotikul & Hsieh, 1989).  
Even with the high market value associated with crawfish they are much appreciated in 
many states across the United States. The market value of Louisiana crawfish exceeds more than 
$170 million annually, reportedly adding $300 million to the state’s economy (Johnson, 2019). 
Crawfish are frequently sold boiled ready to eat, live in sacks for crawfish boils, or as frozen 
 2 
peeled tail-meat. In times of oversupply, large crawfish remain in the live market and sometimes 
smaller crawfish are produced for meat (Editor, 2010). These undersized, also termed 
underutilized crawfish, have very little market value and are often discarded. Subsequently, this 
has resulted in an increase in the production of crawfish waste, or byproducts from processing. 
The utilization of undersized crawfish or the shells from peeling operations for the extraction of 
astaxanthin may increase the economic value of crawfish.  
The Louisiana crawfish culture industry has been reported to be the largest crustacean 
farming operation in the United States for more than 30 years. Much, if not most, of the crawfish 
production is consumed and or processed in the state within two relatively concentrated areas, 
Breaux Bridge, LA and Crowley, LA (Laudun, 2016; Mulcahy, Naquin, & Harper, 2019; Poudel, 
2016; Richardson, 2015). Therefore, there should be a stable supply of byproducts for conversion 
into alternative products. There is a great potential in the crawfish processing industry to convert 
previously discarded byproducts into valuable products. Please note that the term byproducts is 
not clearly defined to distinguish it from waste and it is often identified as leftovers that are not 
ordinarily saleable, rather than potentially valuable components that can be used with proper 
treatment. 
1.2 Antioxidants 
The prevention of diseases is important to health and well-being. People are encouraged 
to eat a well-balanced diet and to exercise, in efforts to avoid illness. Antioxidants are reported to 
play a noteworthy role in both the prevention and treatment of diseases. Antioxidants are 
naturally found in fruits and vegetables or can be additives used to preserve food from “farm to 
table”, that prevent deterioration in storage and processing (Griffiths et al., 2016). Antioxidants 
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may also be present in health and beauty products like face creams and shampoo. They function 
to combat oxidation of compounds in products that result in the loss of functional quality.  
All biological systems exist in redox equilibrium, balancing reducing and oxidative 
reactions to meet necessary conditions for life (Gaschler & Stockwell, 2017). An imbalance of 
the aforementioned redox equilibrium results in potentially severe biological damage. In the case 
of aerobic organisms, oxidation is a normal metabolic process in which energy is produced 
through a series of reactions that involve oxidants. When there is an overproduction of ROS, 
such as the superoxide anion radical (%"&), hydrogen peroxide ('"%"), and the hydroxyl radical 
(HO*) or reactive nitrogen species (RNS), the biological redox balance called redox equilibrium 
is tilted, creating oxidative stress (Figure 1.1). Antioxidants function to combat oxidative stress 
in the body. These include non-enzymatic scavengers such as vitamin C and E, glutathione 
(GSH), lipoic acid, carotenoids and iron chelators, as well as enzymatic scavengers such as 
superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx) and peroxiredoxins (Redza-
Dutordoir & Averill-Bates, 2016). Conversely, an overproduction of reductants leads to 
reductive stress (Woods, Wilund, Martin, & Kistler, 2012). 
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Figure 1.1. Balance of redox equilibrium. Source: Spickett, Fedorova, Hoffmann, and Forman 
(2015) 
The beneficial effects of natural antioxidants found in fruits and vegetables are related to 
three major groups: carotenoids, phenolics, and vitamins. Of the three categories, carotenoids are 
known as lipophilic antioxidants, with the others being hydrophilic (Thaipong, Boonprakob, 
Crosby, Cisneros-Zevallos, & Hawkins Byrne, 2006). Antioxidants compounds may be produced 
in the body or obtained from food or supplements, and may be either natural or man-made. As 
mentioned earlier, antioxidants prevent foods from spoiling, Examples of natural antioxidants 
include SOD and GPx, both produced by the body, and chemical antioxidants, such as the 
carotenoids, vitamin E, lutein, and astaxanthin, all dietary. Antioxidants can prevent certain types 
of cell damage or lipid oxidation induced by oxidative stress. They have also been used as 
reactive oxygen species scavengers to eliminate oxidative stress. 
Several carotenoids act as potent antioxidants. Antioxidants have various health benefits, 
including prevention of ocular disease, reduction of inflammation, prevention of Alzheimer’s 
disease, reduction of the risk of stroke, and the improvement of blood glucose in diabetic therapy 
Biological Redox Balance
A delicate balance between oxidizing compounds and reductants
Reactive Oxygen Species Antioxidants Oxidative Stress
Balanced
Reductive Stress
Imbalance when production of defenses is unfavored
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(Bahonar, Saadatnia, Khorvash, Maracy, & Khosravi, 2017; Behl & Moosmann, 2002; C. Li et 
al., 2017; N. Singh & Ghosh, 2019). Recently antioxidants were reported to reduce the incidence 
of coronary heart disease and prevent cancers. A more detailed discussion follows. 
1.2.1 Reduction of inflammation 
Oxidative stress triggers the release of cell signaling proteins, chemokines, cytokines, and 
activation of their receptors as well as lipid peroxidation in the human body. Resulting in the 
generation of pro-inflammatory, which are not an indication of the abnormalities directly caused 
by the disease but are due to the activation of the body’s defense mechanisms. However, this 
self-defense mechanism, collectively termed inflammation, may become harmful if it transforms 
into chronic inflammation (Levine, Mizushima, & Virgin, 2011). For example, Helicobacter 
pylori, a Gram-negative bacterium, causes chronic gastritis. The pathogenesis is partly caused by 
an immunological response and affects roughly half of the world population. Astaxanthin was 
shown to attenuate gastritis caused by H. pylori infections by inhibiting the growth of the 
bacterium, to ultimately suppress gastric inflammation (Bennedsen, Wang, Willén, Wadström, & 
Andersen, 2000). Additionally, Kang and Kim (2017) found that the inflammatory response 
impairment stimulated by H. pylori-infected gastric tissues is abated by astaxanthin modulating 
the cellular response to shift the activation of T helper cell type 1 response towards T helper type 
2 response.  
1.2.2 Cancer prevention 
Not only does the intake of dietary fats (i.e. saturated fats) promote the development of 
coronary heart disease, they have also been linked to the development of certain cancers because 
of the chemical changes they can undergo during thermal processing (Kolonel, 2001; Norat et 
al., 2005). An approach to combat such deleterious effects has created much interest foods for 
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cancer prevention, an interest in bioactive compounds, like antioxidants, from fruits and 
vegetables has been promising. The importance of oxidative damage in the etiology of human 
cancer and the need for intrinsic and dietary antioxidants was first studied by the American 
biochemist, Dr. Bruce Ames. Most notably, Dr. Ames is known for the development of the Ames 
test, which is an assay for mutagens and their potential to be carcinogenic. Researcher Totter 
(1980) reported that oxygen radicals and lipid oxidation agents are contributors to DNA damage 
that results in diseases like cancer. He also reported that tocopherol, a radical trap in lipid 
membranes, was used in a variety of oxygen-related diseases and that it was capable of 
ameliorating the damage and carcinogenicity of several quinones. In the same report, it was 
mentioned that β -carotene in green and yellow vegetables in the diet may be anticarcinogens and 
inhibits tumorigenesis is several cancer models in vivo (Shree et al., 2017; Totter, 1980). The 
main carotenoid found in aquatic animals, microorganisms and seafood, astaxanthin has attracted 
considerable attention in part due to it being more potent than that of β -carotene and other 
carotenoids as it relates to its antitumoral activity (Palozza et al., 2009) 
Several epidemiological studies indicate an association between nutritional habits and 
prevention of several types of cancer (Campbell, Newton, Jacobs, Pollak, & Gapstur, 2019; 
Emenaker & Vargas, 2018; Susan T Mayne, Playdon, & Rock, 2016). The relationship between 
nutrition and cancer dates back before the 1940s, when researchers first considered that 
restricting diet, namely a caloric restriction, resulted in delayed growth and development of 
mouse carcinomas (Bischoff & Long, 1938; Sugiura & Benedict, 1936; Tannenbaum, 1940). 
Nowadays, with the advancements in the fields of molecular biology, medicine, nutrition and 
technology since the mid 20th century, researchers have turned the focus from not only caloric 
restriction but to the restriction of foods thought to promote cancer and foods that contain cancer 
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preventing components (antioxidant micronutrients).  
1.3 Xanthophyll carotenoid: astaxanthin 
Carotenoids, are non-polar, fat-soluble tetraterpenes consisting of linked isoprene units 
found in nature and responsible for imparting color to pigments of many fish and shellfish 
(Lindshield, 2012; Martínez-Delgado, Khandual, & Villanueva–Rodríguez, 2017; N. M. 
Sachindra, Bhaskar, & Mahendrakar, 2005). Carotenoids are classified in two ways, whether or 
not it is capable of being converted to Vitamin A, and on structural differences and polarity. The 
oxygenated carotenoids are known as xanthophylls, whereas hydrocarbon carotenoids are known 
as carotenes (Lindshield, 2012). 
Natural pigments are found widespread in all living matter including mammals, fungi, 
invertebrates, and marine algae (Delgado-Vargas, Jiménez, & Paredes-López, 2000). The 
carotenoid family consists of more than 700 pigments synthesized de novo in higher plants, 
mosses, algae, bacteria, and fungi whose structures are derived from the acyclic isoprenoid 
lycopene (I. Higuera-Ciapara, Felix-Valenzuela, & Goycoolea, 2006; Jackson, Braun, & Ernst, 
2008; Khachik, Beecher, & Smith Jr, 1995). There are two important classifications of 
carotenoids; carotenes, a subclass composed of only hydrocarbons, and xanthophylls, a subclass 
consisting of oxygenated derivatives of carotenes (Jackson et al., 2008).  
Several carotenoids act as potent antioxidants in humans and have been investigated 
because of their ability to lessen the damaging effects of ROS. A carotenoids ability to efficiently 
scavenge free radicals and to absorb light in the visible region is due to the multiple conjugated 
double bonds contained within its structure (Lindshield, 2012). Plants employ carotenoids light 
harvesting ability in the complex that captures light for photosynthesis. Carotenoids are also 
found in bacteria, yeasts, molds crustaceans and bird feathers. Mammals do not synthesize 
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carotenoids; therefore, they must be obtained through diet.  
Additionally, seafood can also be a source of marine natural pigments (Ferraro et al., 
2010). Chlorophylls, carotenoids and phycobiliproteins are three basic classes of natural 
pigments found in seafood (Noomhorm, Ahmad, & Anal, 2014). Crawfish and shrimp 
byproducts, contain high levels of health benefitting bioactive compounds, such as proteins, 
carotenoids, minerals, pigments and flavor compounds (Ibrahim, Salama, & El-Banna, 1999). 
Astaxanthin, a xanthophyll carotenoid synthesized by plants and algae and found in crustaceans, 
is a well-known antioxidant with multiple health promoting qualities has gained much attention 
recently (Ambati, Phang, Ravi, & Aswathanarayana, 2014). 
Due to its outstanding antioxidant activity, astaxanthin is capable of providing protection 
against cardiovascular diseases, different types of cancer, some diseases of the immunological 
system, macular degeneration and age-related cataracts, the latter two being related to light-
induced oxidative processes in the eye (Guerin, Huntley, & Olaizola, 2003; I. Higuera-Ciapara et 
al., 2006). Some research has shown the ability of astaxanthin to ameliorate triglycerides (TG) 
and high-density lipoproteins (HDL) in animal studies, thus potentially improving lipid profiles 
in humans (H. Yoshida et al., 2010). Additionally, the structure of astaxanthin makes it a more 
potent anti-oxidant than β-carotene (Jackson et al., 2008). 
Albeit astaxanthin having the capability of exerting antioxidant effects, it does so without 
being a pro-oxidant. Pro-oxidants induce oxidative stress by hindering antioxidant systems or 
generating reactive oxygen species. It is known that reactive oxygen species are the underlying 
cause of many diseases and illnesses.  
1.3.1 Chemical Structure 
The carotenoid family consists of more than 700 pigments synthesized de novo in higher 
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plants, mosses, algae, bacteria, and fungi divided into two groups, whose structures are derived 
from the acyclic isoprenoid lycopene, seen in Figure 1.2 (I. Higuera-Ciapara et al., 2006; Jackson 
et al., 2008). The two groups are based on the chemical elements they contain in their molecules: 
carotenes, which are composed of only hydrocarbons, and xanthophylls, consisting of 
oxygenated derivatives of carotenes (Jackson et al., 2008). The oxygen present in xanthophylls 
may be present as hydroxyl (OH) groups, carbonyl (C=O) groups or as a combination of both. 
Astaxanthin, a xanthophyll carotenoid, which is synthesized by plants and algae from lycopene 
by oxidative functionalization, has strong antioxidant properties (Ambati et al., 2014). The 
presence of OH and C=O in each ionone ring contribute to the strong antioxidant capacity of 
astaxanthin and its ability to be esterified.  
 
Figure 1.2. Carotenoid biosynthesis from lycopene. Source: Jackson et al. (2008). 
Astaxanthin (3,3′-dihydroxy-β, β-carotene-4,4′-dione) is carotenoid pigment containing 
11 conjugated double bonds and two hydroxyl groups, Figure 1.3 (Martínez-Delgado et al., 
2017). The long chain of conjugated double bonds (polyene) and two terminal ring systems 
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(ionone rings) determine its chemical characteristics and light absorption properties of 
astaxanthin. In nature, astaxanthin is found in three trans isomer, however the 3S, 3S’, seen in 
Figure 1.4, is the most common (Coral-Hinostroza, Ytrestøyl, Ruyter, & Bjerkeng, 2004; I. 
Higuera-Ciapara et al., 2006). Due to the different chirality at C-3, 3′, astaxanthin has three R/S 
(optical) isomers including two enantiomers (3S,3′S) and (3R,3′R) and the meso form (3R,3′S) 
(Figure 1.4). 
 
Figure 1.3. Chemical structure of astaxanthin. Source: Lorenz and Cysewski (2000) 
 
Figure 1.4. Structures of optical isomers all-E-astaxanthin. Source: Coral-Hinostroza et al. 
(2004)  
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All-E configuration (a, straight chained) and the three Z configurations (b, c, and e, bent 
chains) in Figure 1.5 below, have greater solubility and improved oral bioavailability (Østerlie, 
Bjerkeng, & Liaaen-Jensen, 2000). 
 
Figure 1.5. Geometrical isomers all-E-, 9Z-, 13Z- and 15Z-astaxanthin. Source: Østerlie, 
Bjerkeng, and Liaaen-Jensen (1999) 
1.3.2 Sources of Astaxanthin 
1.3.2.1 Microorganisms 
The primary source of the carotenoid astaxanthin present in aquatic animals is algae, 
namely Haematococcus pluvialis, the most abundant source of natural astaxanthin (Guerin et al., 
2003; Maoka, 2011; Matsuno, 2001). Astaxanthin, a red fat-soluble xanthophyll carotenoid, can 
be found in various microorganism (Table 1.1) including yeast, algae, bacteria (Asker, Beppu, & 
Ueda, 2007; J. H. Lee, Kim, Choi, Lee, & Kim, 2004; Lemoine & Schoefs, 2010; Libkind, 
Moliné, de García, Fontenla, & van Broock, 2008). Commercial astaxanthin is mainly from 
Phaffia yeast, Haematococcus and through chemical synthesis. 
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Table 1.1 Sources of Astaxanthin 
Sources Astaxanthin (%) on a Dry Weight Basis References 
Alphaproteobacteria   
Agrobacterium aurantiacum 0.01 (Yokoyama and others 1995) 
Paracoccus carotinifaciens (NITE SD 
00017) 2.2 (Borie 2007) 
Chlorophyceae   
Haematococcus pluvialis 3.8 
(Ranga and others 
2009: Ranga Rao 
and others 2010) 
Haematococcus pluvialis (K-0084) 3.8 (Aflalo and others 2007) 
Haematococcus pluvialis (Local 
isolation) 3.6 
(Torzillo and others 
2003) 
Haematococcus pluvialis (AQSE002) 3.4 (Olaizola 2000) 
Haematococcus pluvialis (K-0084) 2.7 (Wang and others 2013) 
Chlorococcum 0.2 
(Zhang and Lee 
1997; Zhang and 
others 1997) 
Chlorella zofingiensis 0.001 (Wang and Peng 2008) 
Neochloris wimmeri 0.6 (Orosa and others 2000) 
Florideophyceae  
Catenella repens 0.02 (Banerjee and others 2009) 
Labyrinthulomycetes   
Thraustochytrium sp. CHN-3 (FERM P-
18556) 0.2 (Yamaoaka 2008) 
Malacostraca   
Pandalus borealis 0.12 (EFSA 2005) 
Pandalus clarkia 0.015 (Meyers and Bligh 1981) 
Tremellomycetes   
Phaffia rhodozyma 0.00001  
Xanthophyllomyces dendrorhous (JH)  0.5 
(Kim and others 
2005)  
(table cont’d) 
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Sources Astaxanthin (%) on a Dry Weight Basis References 
 
Xanthophyllomyces dendrorhous (VKPM 
Y2476) 
0.5 (de la Fuente and others 2010) 
Ulvophyceae   
Enteromorpha intestinalis 0.02 (Banerjee and others 2009) 
Ulva lactuca 0.01 (Banerjee and others 2009) 
 
1.3.2.2 Seafood byproducts 
Astaxanthin is the primary naturally occurring pigment in marine crustaceans and in the 
flesh of salmonids (Felix-Valenzuela, 2001). Unable to synthesize the pigment, these marine 
creatures obtain the astaxanthin from their environment, or if farmed commercially, through their 
feed. Byproducts from crustaceans are produced during processing operations for recovery of the 
edible portion of crabs, crawfish, shrimp, and lobster; and consist of mineral salts, proteins, 
chitin, lipids, and pigments. Natural marine fishery sources of astaxanthin are salmon, trout, krill, 
crawfish and shrimp (Ambati et al., 2014). Astaxanthin, the predominant carotenoid found in 
crustacean waste is free or esterified with fatty acids (De Holanda & Netto, 2006; Kim, Perera, 
Rajapakse, & Kim, 2014). Crab, salmon and shrimp can serve as dietary sources of astaxanthin 
(Authority, 2005) 
1.3.2.3 Chemical synthesis 
There are 5 C40 carotenoids manufactured synthetically, from petroleum feedstocks, on 
an industrial scale (i.e. including ß,ß-carotene, lycopene, canthaxanthin, zeaxanthin, and 
astaxanthin) for use as nutritional supplements and for animal feed additives in poultry farming 
and aquaculture that are essential for the animals' growth, health and reproduction (Jackson et al., 
2008). The most widely used method of producing synthetic astaxanthin is the Wittig reaction is 
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produced in an isomeric form similar to the form predominately found in nature (Ernst, 2002). 
Synthetic astaxanthin is a racemic mixture (1:2:2:1) of all three-isomers (3S, 3S’), (3R, 3R’), 
(3S, 3R’) and (3R, 3S’), respectively) as seen in Fig 1.6 (I. Higuera-Ciapara et al., 2006). 
Synthetic astaxanthin is identical molecularly to that produced in living organisms, and is the 
main carotenoid used in the aquaculture industry throughout the world (I. Higuera-Ciapara et al., 
2006).  
 
Figure 1.6. Synthetic astaxanthin stereoisomers. Source: I. Higuera-Ciapara et al. (2006) 
Studies have shown that both natural and synthetic astaxanthin produce satisfactory 
effects, but human trials for natural astaxanthin are lacking due to production availability as 
evidence by several studies. Furthermore, there has not been any established recommended dose 
for astaxanthin daily intake, however most research findings report benefits from a daily intake 
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of 4mg. Despite the low cost for manufacturing synthetic carotenoids, there is a deleterious 
impact on the environment, and growing health concerns, there is an increasing demand for more 
natural sourced compounds; this has led many researchers to investigate natural sources of 
astaxanthin, such as crustacean byproducts (Cheng & Yang, 2016; Dalei & Sahoo, 2015; Gateau, 
Solymosi, Marchand, & Schoefs, 2017; Gupta, Jha, Pal, & Venkateshwarlu, 2007; Ye, Jiang, & 
Wu, 2008).  
1.3.3 Uses of Astaxanthin 
Astaxanthin has several patented applications available in feed, food, nutraceutical and 
pharmaceutical applications (Ambati et al., 2014). Nutraceuticals are physiologically beneficial 
foods that protect against chronic diseases (Hughes, Marangoni, Wright, Rogers, & Rush, 2009). 
AX products are available in many different forms, from capsules, soft gels, tablets and energy 
drinks to powder, oil, biomass, cream, oil and extracts. 
Mammals, fish and crustaceans are unable to synthesize astaxanthin de novo, thus it must 
be obtained from their diet, or partly modified through metabolic reactions (Liaaen-Jensen, 1990, 
1998; Maoka, 2011; Matsuno, 2001). In nature astaxanthin, biosynthesized in plants, algae, and 
some bacteria and fungi, is absorbed (dietary) and metabolized by mammals, fish and 
crustaceans (H.-M. Chen & S. P. Meyers, 1982) accumulating in the skin, muscle or exoskeleton. 
That results in the colors seen in flamingos, salmon, shrimp crawfish and rainbow trout (Shahidi 
& Synowiecki, 1991).  
1.3.4 Recovery of Astaxanthin 
Several techniques have been used to extract astaxanthin from microorganisms 
(microalgae, bacteria, and yeast), marine organisms (shrimp, crabs, crawfish and lobster) and 
wastewater. Such techniques include acid, alkaline, and enzymatic treatments, vegetable oils and 
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solvents with supercritical fluid extraction, ultrasound-assisted extraction, and ultrafiltration 
(Amado, González, Murado, & Vázquez, 2016; Gimeno et al., 2007; Qing, 2010; N. Sachindra & 
Mahendrakar, 2005; Sánchez-Camargo, Meireles, Ferreira, Saito, & Cabral, 2012). 
1.3.4.1 Organic Solvents 
Recovery of carotenoids (astaxanthin) from crustacean species have also been done using 
acetone, ethanol, methanol, isopropyl alcohol and ethyl acetate. N. Sachindra, Bhaskar, and 
Mahendrakar (2006) found that, compared to acetone, ethanol, isopropyl, methanol, petroleum 
ether, and ethyl acetate, a 50:50 mixture of isopropyl alcohol and hexane gave the highest 
carotenoid extraction yield (43.9 μg/g waste).  
Extraction of astaxanthin with the use of solvents include supercritical (SC) fluid 
extraction (SFE) using carbon dioxide (CO2) and a co-solvent, like an organic solvent (i.e. 
ethanol). This extraction technique offers several advantages including low temperatures, low pH 
to stabilize astaxanthin, and minimal to no oxygen and light exposure to cause oxidative or 
thermal deterioration (Charest, Balaban, Marshall, & Cornell, 2001; Torrissen, Tidemann, 
Hansen, & Raa, 1981). Studies using SC-CO2 with ethanol, showed a significant increase in the 
extraction yield astaxanthin compared to SC- CO2 without ethanol (Charest et al., 2001; Nobre et 
al., 2006; Sánchez-Camargo et al., 2012).   
1.3.4.2 Acids and Enzymes 
Depending on the condition for extracting carotenoids, some techniques have resulted in 
50% losses of the carotenoid. To lessen the deleterious effects of certain techniques, pretreatment 
steps are suitable to increase the efficacy of extraction methods. Such pretreatment alters the 
matrix that carotenoids may be bound to. Barzana et al. (2002) use of enzymes to extract 
carotenoids from marigold flowers (Tagetes erecta) eliminated silage and drying processes that 
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resulted in considerable degradation of lutein, the predominate carotenoid. As mentioned before 
natural carotenoids are found in crustaceans as a carotenoprotein (protein-pigment) complex. 
Separating the carotenoprotein complex with enzymatic pretreatment prior to solvent extraction 
yielded a greater concentration of astaxanthin in hydrolyzed (38.91 μg/g) samples, compared to 
nonhydrolyzed (27.89 μg/g) samples (Armenta-Lopez 2002). 
1.3.4.3 Edible Oils 
Astaxanthin is a lipid soluble pigment, thus, many edible oils have been used as solvents 
to extract this pigment from crustaceans and fish byproducts (H. M. Chen & Meyers, 1984; 
Shahidi & Synowiecki, 1991). Such edible oils are mainly vegetable origin. N. Sachindra and 
Mahendrakar (2005) used different vegetable oils such as groundnut oil, sunflower oil, gingerly 
oil, coconut oil, rice bran oil, and mustard oil to compare extraction yields of carotenoids from 
shrimp byproducts and concluded that refined sunflower oil gave the highest extraction yield. In 
a study by Pu, Bechtel, and Sathivel (2010), flaxseed oil was used to extract astaxanthin from 
shrimp byproducts. It was noted that astaxanthin lowered the oxidation rate of the flaxseed oil.   
Additionally, (Krichnavaruk, Shotipruk, Goto, & Pavasant, 2008) SC- CO2 extraction of 
astaxanthin from H. pluvialis was done with the soybean oil and olive oil. The highest extraction 
efficiency obtained, of 36.36 ± 0.79% and 51.03 ± 1.08%, respectively, was obtained and was far 
greater than what was extracted with pure SC- CO2 (25.4 ± 0.79%). 
The major pigments in oil extract are monoesters and diesters, suggesting that these esters 
are preferentially extracted by the oils. The extracted, esterified astaxanthins are considered to be 
less prone to oxidation than free astaxanthin (Omara-Alwala, Chen, Ito, Simpson, & Meyers, 
1985). Free astaxanthin is either esterified with one or two fatty acids (FAs), or conjugated to 
proteins (carotenoprotein complex), such as in salmon and mussel muscle or snow crab and 
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lobster exoskeleton (Guerin et al., 2003; Henmi, Hata, & Hata, 1989; Manu-Tawiah & Haard, 
1987; Ya et al., 1991; H.-P. Yang, Lee, Kim, & Kim, 1994)  
1.3.4.4 Ultrasound Assisted Extraction 
The major markets of astaxanthin sourced from H. pluvialis are nutraceutical and 
aquaculture markets. Inexpensive and less harsh physicochemical and cell disruption extraction 
methods (reduced toxicity and contamination from chemicals/solvents, and reduced structural 
changes by thermal treatments) are needed to yield increased amounts of naturally derived 
bioactive astaxanthin. 
Novel extraction techniques have received a great deal of attention to overcome 
drawbacks of conventional extraction techniques. Drawbacks of conventional methods include 
the use of large amounts of solvents, exposure to elevated temperatures, lower extraction yields 
and prolonged extraction times. Novel techniques include supercritical carbon dioxide (SC- CO2) 
extraction, microwave assisted extraction, and ultrasound assisted extraction (UAE). UAE has 
been used to extract and detect compounds in animals' structures and plant tissues (Kadam, 
Tiwari, & O’Donnell, 2013; Nessa, Khan, & Al Khatib, 2010; Vinatoru, Mason, & Calinescu, 
2017; Yue, Xu, Prinyawiwatkul, & King, 2006).  
Several proposed theories exist for explaining the extracting enhancement of UAE (F. 
Chemat et al., 2017). For extraction of astaxanthin from H. pluvialis, the theory of operation may 
be described as a detexturation effect. Detexturation of plant structures were noticed in a study 
on essential oil extraction by S. Chemat, Lagha, AitAmar, Bartels, and Chemat (2004). In their 
study, scanning electron micrographs showed gradual physical alterations (degradation of cell 
walls) with increasing processing times, between conventional extracted and UAE of caraway 
seeds used as a model compound. Such characteristic cell wall degradation favors accessibility of 
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the solvent to the intracellular components, rather than relying on diffusion alone, as in 
conventional extraction techniques. In a separated study modeling the extraction of astaxanthin, 
UAE improved the extraction efficiency of astaxanthin, when chemical and mechanical cell 
disruptions techniques were compared (D. Singh et al., 2015). 
1.4 Lipid Digestion and Absorption 
The gastrointestinal (GI) system, Figure 1.7, is responsible for the digestion and 
absorption of lipids. There are specific processes involved in the digestion and absorption of 
dietary lipids through the water-soluble environment of the GI tract (Lichtenstein & Jones, 
2012). Dietary lipids (TG, phospholipids, steroids, and fat-soluble bioactive compounds) may be 
liquid or solid depending on temperature, and are referred as fats and oils, respectively. The bulk 
of dietary lipids are TG, which consist of a glycerol molecule esterified to three FAs. 
1.4.1 Digestion 
The first step of digestion begins in the mouth with salivation and mastication. Lohse et al 
(2007) suggested lingual lipase, produced by von Ebner’s glands, starts the hydrolysis of free 
FAs from triacylglycerols (TAGs). TAGs are cleaved at the sn-3 position by lingual lipase, with 
increased efficiency towards short-chained FAs (Carey, Small, & Bliss, 1983). Carriere et al. 
(1993) reported that in the stomach, hydrolysis of TAGs continues with gastric lipase, secreted 
by chief cells of the gastric mucosa. Gastric lipase also cleaves TAG at the sn-3 position 
(Lichtenstein & Jones, 2012). The fat entering the upper duodenum is approximately 70% TG 
while the remainder is a mixture of partially digested hydrolysis products known as chyme. 
The small intestine, the site where the majority of lipid digestion and absorption occurs,  
requires the actions of bile salts and pancreatic lipase, the principle enzyme involved in TAG 
digestion , which hydrolyzes ester bonds at the sn-1 and sn-3 positions (Canaan, Roussel, Verger, 
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& Cambillau, 1999; J.H.Peter & Rideout, 2010; Mu & Høy, 2004). Bile salts, phospholipids, and 
sterols are all lipid components of bile. Bile, an emulsifying fluid, is secreted directly from the 
liver and stored in the gall bladder in response to the presence of fat in the duodenum 
(Lichtenstein & Jones, 2012). The gall bladder also secretes pancreatic lipase. During digestion, 
lipids dissolve hydrophobic compounds and cause an increase in the secretion of bile from the 
gall bladder, which subsequently leads to the micellization of lipids (Hughes et al., 2009). 
Dietary mixed micelles are formed in the small intestine by 2-monoaclyglycerol and free FAs 
(hydrolytic products of TAG), bile salts, phospholipids, unesterified cholesterol, and other fat-
soluble substances (Salvia-Trujillo et al., 2017). Subsequently, the decreased size of the formed 
micelles and increased surface area over larger droplets aids in further solubilization and 
digesrtion of carotenoids (Furr & Clark, 1997). 
 
 
Figure 1.7. Gastrointestinal system anatomy. Source: https://www.saintlukeskc.org/health-
library/anatomy-digestive-system. 
 
 
 21 
1.4.2 Absorption of Carotenoids: Astaxanthin 
A number of factors, described by the mnemonic “SLAMENGHI”, affect the absorption 
of carotenoids. Species, Linkage, Amount of carotenoid consumed in a meal, Matrix, Effectors, 
Nutrient status, Genetic factors, Host-related factors, and Interactions (Castenmiller & West, 
1998; Lindshield, 2012). Species refers to the carotenoid being a xanthophyll or carotene, and 
relates to it geometric isomerism (BeMiller, 1986) The molecular linkage, whether free or 
esterified to FAs, is important for absorption also. The matrix refers to the accessibility of the 
carotenoids, being unbound or bound, becoming solubilized in micelles within the GI tract 
(Lindshield, 2012). It is critical for absorption to free carotenoids from bound matrices to 
improve uptake and increase bioavailability. Many effectors may contribute to the efficient 
absorption and bioconversion of carotenoids.  
Diets consisting of many fruits and vegetables delay the onset of many age-related 
diseases, and contain a complex mixture of antioxidants (ascorbic acid, vitamin E, flavonoids, 
and carotenoids) (Everitt et al., 2006; S. Wang, Melnyk, Tsao, & Marcone, 2011). Since 
carotenoid are lipi-soluble, their absorption follows that of dietary fats. Additionally, intestinal 
absorption of carotenoids involves several critical steps: 1) release from the food matrix, 2) 
solubilization into mixed micelles in the lumen, 3) cellular uptake by intestinal mucosal cells, 4) 
incorporation into chylomicrons and 5) secretion of carotenoids and their metabolites associated 
into the lymph (E. H. Harrison, 2012). A number of factors affect the absorption of carotenoids, 
like species, linkage, amount, matrix, effectors, nutrient status, genetic factors, host-related 
factors, and interactions (Lindshield, 2012). Species refers to the carotenoid belonging to a 
group, xanthophyll or carotene, and relates to its geometric isomerization. However, the 
bioavailability of carotenoids is low, and varies from more than 50% in oily solutions to less than 
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10% from raw uncooked vegetables (Hinnant, Oh, Caburnay, & Kreuter, 2011; Olson, 1999). 
This low bioavailability reduces the distribution within the body by lowering the efficacy and 
potency of the carotenoid’s therapeutic effects. Between the two groups of carotenoids, 
xanthophylls are ordinarily more readily absorbed than carotenes in part due to their hydrophobic 
nature, allowing them to be incorporated into the outer portion of lipid micelles in the lumen 
preceding absorption (Mercke Odeberg, Lignell, Pettersson, & Höglund, 2003; Yeum & Russell, 
2002).  
Bioavailability of astaxanthin is also be dependent upon digestion, intestinal absorption, 
and delivery to tissues (Couëdelo et al., 2010). The molecular linkage, whether free or esterified 
to FAs, is important for absorption. The matrix refers to the accessibility of the carotenoids, 
being unbound or bound, becoming solubilized in micelles in the GI tract (Lindshield, 2012). 
Many effectors contribute to the efficient absorption of carotenoids. Bioavailability of 
carotenoids is affected by the presence, amount, and type of lipid in the digestive tract at the time 
of absorption (Hughes et al., 2009). 
Distribution of carotenoids among lipoproteins varies between carotenes and 
xanthophylls. The hydrophobic carotenes are found predominately in low-density lipoproteins. 
Guerin et al. (2003), reviewed the steps of digestion, absorption and plasma transport of 
carotenoids in mammals and found that polar carotenoids, such as astaxanthin, are likely to be 
transported by low-density lipoproteins (LDLs) and high-density lipoproteins (HDLs). Humans 
(along with monkeys, gerbils, and ferrets, but excluding rats, and mice unless given very high 
doses) absorb a significant portion of intact carotenoids directly and circulate or accumulate 
them in their plasma, liver, and peripheral tissue (X.-D. Wang, 2012). Things like vitamin A 
status, protein deficiency, and iron status are also known to affect absorption efficiency. Host 
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illnesses like atrophic gastritis, the process of chronic inflammation of the stomach mucosa, 
decreases carotenoid uptake due to insufficient gastric acid secretion, which disturbs the 
formation and absorption of mixed micelles (Yeum & Russell, 2002). 
During digestion, lipids dissolve hydrophobic compounds and increase bile secretion 
from the gall bladder, which in turn leads to their solubilization for micellarization (Hughes et 
al., 2009). Inefficient absorption of astaxanthin may be due to several factors; including 
astaxanthin being embodied in food matrices, dissolution limitations in the GI fluids (E-isomer), 
and a saturated capacity of incorporation into bile micelles (Parker, 1996). X.-D. Wang (2012) 
suggested that food processing that causes mechanical breakdown of the food matrix and 
subsequent release of carotenoids can improve intestinal absorption, as in boiling of crustaceans 
like shrimp and crawfish.  
1.5 Flaxseed Oil 
In addition to the many health protecting benefits that AX has to offer and the potential to 
use an otherwise discarded material which may present environmental concerns, it would be 
ideal to use crustacean processing byproduct material as a natural source. A simple food 
processing method or heating can cause the mechanical breakdown of the matrix and release of 
the carotenoid, AX, from the processing byproducts (X.-D. Wang, 2012). Additionally, since AX 
is a lipophilic compound it can be extracted from processing byproducts using many plant 
derived edible oils, such as flaxseed oil. 
Flaxseed oil, cold pressed from flax (Linum usitatissimum), or linseed,  has gained a lot 
of attention due to its exceptional nutrient profile and protective effects against cardiovascular 
disease, inflammation, and some cancers (Bloedon & Szapary, 2004; C. R. Harper, Edwards, 
DeFilipis, & Jacobson, 2006; Tzang et al., 2009). Flax is the richest plant source of a-linolenic 
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acid (ALA; C18:3n-3), an omega-3 (n3) FA and lignans (phytoestrogens) (Barceló-Coblijn et al., 
2008; Goyal, Sharma, Upadhyay, Gill, & Sihag, 2014; Oomah & Agriculture, 2001).  
The importance of fat, and its lack thereof to severely impact growth and reproductive 
development in experimental animals was demonstrated by Evans and Burr (1927), despite the 
administration of fat-soluble vitamins. The works of the Burrs led to the discovery that FAs were 
crucial to health, and a deficiency could often lead to death. ALA is considered an essential fatty 
acid (EFA), a term coined by Burr and Burr (1930) for those FAs not synthesized by mammals 
and for which deficiencies could be reversed by dietary FA addition. ALA is a precursor of the 
n-3 FA family, the other being linoleic acid (LA); neither can be synthesized, in vivo (Jeffcoat & 
James, 1984). In vivo synthesis cannot occur because mammals lack the desaturase enzymes 
required to synthesize double bonds at the n-3 and n-6 position of the carbon chain of FAs. 
Therefore n-3 and n-6 FAs must be obtained from the diet (Jeffcoat & James, 1984; J. Lee, Lee, 
Kang, & Park, 2016). ALA is also a precursor to the long chain (n-3) polyunsaturated FAs 
(PUFA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (C. R. Harper et al., 
2006).  
Of the total lipid content in flaxseed, thirty percent is composed of 100% lipids, of which 
53% are ALA, 17% LA, 19% oleic acid, 3% stearic acid, and 5% palmitic acid; all of which 
provide an excellent n-6: n-3 FA ratio of approximately 0.3:1 (Simopoulos, 2002).  
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Table 1.2. Fatty acid content of flaxseed oil 
Fatty Acids Percentage (%) (Range) 
Palmitic acid (C16:0) 4.90-8.00 
Stearic acid (C18:0) 2.24-4.59 
Oleic acid (C18:1) 13.44-19.39 
Linoleic acid (C18:2) (⍵-6) 12.25-17.44 ⍺-Linolenic acid (C18:3) (⍵-3) 39.99-60.42 
Sources: (Anwar, Zreen, Sultana, & Jamil, 2013; Bozan & Temelli, 2008; Choo, Birch, & 
Dufour, 2007a; Guimarães et al., 2013; Khattab & Zeitoun, 2013; Pradhan, Meda, Rout, Naik, & 
Dalai, 2010; Pu et al., 2010; Quispe-Condori, Saldaña, & Temelli, 2011; Z.-S. Zhang et al., 
2008; Z.-S. Zhang, Wang, Li, Li, & Özkan, 2011). 
 
Flaxseed oil is low in saturated FAs, moderate in monosaturated FAs, and rich in PUFAs 
(polyunsaturated fatty acids), with ALA being the major FA (Table 1.2) (Goyal et al., 2014). 
Flaxseed oil provides the highest amount of ALA (40-60 wt% of total FAs) among various 
vegetable sources (Couëdelo et al., 2010). In other words,  The antioxidant properties of ALA, 
like cardio protection, and other beneficial health effects of ALA have been attributed to its 
precursor role in converting to EPA in the body (Rajaram, 2014). 
1.6 Lipid Oxidation 
The general term used to describe complex sequences of chemical changes that result 
from the interactions between lipids and oxygen is known as lipid oxidation, or autooxidation at 
times (Damodaran & Parkin, 2017). Lipid oxidation can either be mediated by enzymes (i.e. 
lipoxygenase, cytochrome P450s, and cyclooxygenases), nonenzymatic and nonradical 
photooxidation, or by nonenzymatic chain autoxidation pathways (i.e. reactions with oxidants 
and free radicals mentioned in the following paragraphs). Both enzymatic and non-enzymatic 
oxidation pathways are responsible for physio-pathological effects seen in cellular functions and 
the development of diseases (Figure 1.8). The last two types of reaction pathways consist of a 
combination of reactions involving triplet oxygen 3O2.  
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PUFAs are more readily attacked by oxidants because of the high number of carbon-
carbon double bonds contained within their structure (Ayala, Muñoz, & Argüelles, 2014). 
Additionally, the high susceptibility of lipids to oxidation is the reason why they are an excellent 
energy source for catabolic metabolism. Lipid oxidation of foods containing lipids during food 
processing and storage is of major concern because it can create undesirable qualities in a 
finished product. Lipid oxidation can be initiated (ensue the formation of free radicals) by a 
number of factors (initiators) including heat, UV and ionizing radiation, peroxides and trace 
metals (i.e. copper or iron ions), reaction (1):  
 3sens 
*+,- 1sens + 3O2 → 1O2               (1) 
 
 
Figure 1.8. Lipid oxidation occurring through both enzymatic and non-enzymatic reactions. 
Source: Sottero et al. (2019) 
 
 27 
During lipid oxidation, the hydroperoxides formed from unsaturated FAs like linoleic acid (LA; 
C18:2n-6) and arachidonic acid (AA; C20:4n-6) readily undergo autoxidation, the key 
mechanism in lipid oxidation, due to the ease of which a hydrogen atom can be abstracted from 
the molecules, forming a free radical. Meaning, the autoxidation rate increases with the degree of 
unsaturation in lipids. The processes of lipid oxidation follow the same order regardless of it 
being in an emulsion or other food product as it does in an oil, and are discussed in further detail. 
Nonenzymatic FA oxidation, also termed autooxidation, can be described by three distinct 
phases, known as initiation, propagation and termination. 
1. Initiation 
It is unlikely for the non-enzymatic unsaturated FA (LH) oxidation, reaction (2), to 
proceed spontaneously because of the high activation energy resulting from the spin barrier 
between lipids and 3O2(Laguerre, Lecomte, & Villeneuve, 2007). Therefore, it begins with the 
homolytic breakdown of hydrogen in the  
LH + 3O2 à LOOH                (2) 
During this step, peroxides are cleaved and formed into alkoxy and hydroxyl radicals and act as 
initiators of subsequent chain reactions (Halliwell & Chirico, 1993). During this initiation step, 
unsaturated FAs (chemical species) with unpaired electrons called the alkyl radical (L*), are 
formed. Lipid oxidation is mostly initiated by hydroxyl (*OH) and hydroperoxyl (HOO*) radicals 
(reaction (3)). Additionally, lipid alkoxyl (LO*) and peroxyl (LOO*) radicals (reaction (4)) can 
act as initiators as well. Hydroxyl radicals have the highest reaction rate with lipids; thus, the 
importance of their reduction is crucial to oxidative stability. Antioxidants can counteract lipid 
oxidation by protecting FAs from oxidation initiators or by stalling the second phase, 
propagation (intercepting radical oxidation propagators).  
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LH + 3O2 à L* + *OH               (3) 
L* + O2 à L* + LOO*               (4) 
2. Propagation 
The propagation phase is primarily a radical chain reaction. During this phase, peroxide 
radicals react with oxygen to form a peroxyl radical (LOO*) which potentially accelerates lipid 
degradation due to its high energy (reaction (5)).  Hydrogen addition to the peroxyl radical 
results in the formation of hydroperoxides (LOOH) and a new L*, the primary oxidation 
compounds that can react with other radicals to form volatile compounds (reaction (6)). In order 
to slow down this reaction, the oxygen level should be very low, or an antioxidant can be used to 
intercept lipid peroxyl (LOO*) radicals, a radical oxidation propagator (Laguerre et al., 2007). 
LOO* + LH à L* + LOOH               (5) 
LOOH à LO* + *OH                (6) 
 
3. Termination  
The propagation phase persists with the transformation (decomposition) of 
hydroperoxides into secondary nonradical compounds. The termination reactions leads to the 
formation of hydrocarbons (dimers), volatile and nonvolatile ketones, alcohols, and oxidized 
triacylglycerols and polymers (Halliwell & Chirico, 1993; Laguerre et al., 2007). When 
polyunsaturated FAs oxidize and become alkyl radicals (R*), they form FA dimers (R-R) and 
hydroperoxide dimers (R-OO-OO-R), the major initial oxidation products susceptible to further 
oxidation or decomposition to secondary reaction products (i.e. short-chain aldehydes, dimers 
(reaction (6)), ketones (reaction (7)) and other oxygenated (non- radical) compounds (reaction 
(8))). A single polyunsaturated hydroperoxide radical (ROO*), primary oxidation compound, can 
generate several types of volatile or nonvolatile molecules.  
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R* + R* à R-R                 (7) 
R* + ROO* à R-OO-OO-R               (8) 
ROO* + ROO* à ROOR + O2              (9) 
The secondary reaction products may undesirably affect the overall quality of foods, including 
flavor, odor, nutritional value and the production of toxic compounds that cause diseases, 
especially within anaerobic environments, i.e., frying oils (Spickett et al., 2015; Vercellotti, St 
Angelo, & Spanier, 1992).  
1.7 Hydrocolloids 
Colloids (e.g., proteins, starches, and fats), never truly dissolve in a solvent, but remain in 
an unstable colloidal dispersion. These dispersions contain particles larger than molecules, yet 
too small to be seen. Hydrocolloids are colloids with an affinity for water. as defined by the 
etymology of the word. Hydrocolloid, of Greek origin with hydro meaning ‘water’ and kolla 
meaning ‘glue’ (Wüstenberg, 2015). Natural hydrocolloids are biopolymers that originate from 
living organisms. Additionally, hydrocolloids will increase the viscosity an aqueous system and 
all will bind and hold water to different extents. The two main uses of hydrocolloids are 
thickening agents in soups, gravies, and sauces and the other use is as a gelling agent is jams, 
jellies and low sugar gels (Saha & Bhattacharya, 2010). A gel is defined as a largely diluted 
system that exhibits no steady flow (Ferry, 1980). Gels are typically made of polymers cross-
linked by covalent or non-covalent interactions to form a network capable of entrapping water 
and low molecular weight materials.  Simply stated, a gel is a transitional phase between a solid 
and a liquid.   A few other functional properties include film formation, encapsulation, and 
improving shelf-life (Paulomi Burey, Bhandari, Howes, & Gidley, 2008; Dickinson, 2003, 
2009). 
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A secondary function of hydrocolloids is reducing the flavor intensity by increasing a 
food products thickness. These are all important factors when formulating a food product or a 
delivery system. Even though most hydrocolloids are polysaccharides from natural sources like 
pectin from citrus peels and apple pomace, and carrageenan from seaweed, some are proteins, 
like gelatin from collagen from animals, and gliadin from wheat (BeMiller, 2008; Paulomi Burey 
et al., 2008; Endress & Christensen, 2009; Mariod & Fadul, 2013; X. Wang, Chen, & Lü, 2014). 
The hydrocolloids gelatin and pectin are two biopolymers capable of forming a gel, the 
in-between phase amid a solid and a liquid. A gel is defined as a largely diluted system that 
exhibits no steady flow (Ferry, 1980). Simply stated, a gel is a transitional phase between a solid 
and a liquid. Gels can be made up of polymers cross-linked by covalent or non-covalent 
interactions to form a network capable of entrapping water and low molecular weight materials. 
Gelation is defined as the phase transition from a state without a gel to a state with a gel, that 
involves the formation of an “infinite” network (Stauffer, Coniglio, & Adam, 1982).  
1.7.1 Gelatin 
Gelatin, Figure 1.9 is obtained from the partial hydrolysis of the polypeptide backbone of 
collagen from pigskin, cattle bones and cattle hide (46%, 29.4%, 23.1% of total production, 
respectively) (Duconseille, Astruc, Quintana, Meersman, & Sante-Lhoutellier, 2015; Karim & 
Bhat, 2008). The name gelatin is derived from the Latin gelata, describing the most 
characteristic quality, i.e. gel formation in water (Ledward, 2000). First used as a glue as far back 
as 600 B.C., gelatin, a biopolymer made of water-soluble protein (85-92%), belonging to a 
unique class of hydrocolloids that have many functions and applications, is now used as a food 
and pharmaceutical ingredient for its gelling and foaming ability (Duconseille et al., 2015; Karim 
& Bhat, 2008). Gelatin is also an essential ingredient in the preparation of a confectionery with a 
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hard, chewy or foamy texture. There are two types of gelatin, type A from acid (mineral acid, pH 
1.5 to 3.0) pretreatment, and type B from alkaline (saturated lime, pH 12.0) pretreatment.  In the 
pharmaceutical industry gelatin in the main ingredient used in making hard capsules. A key 
feature of such capsules is that they melt at temperatures above 30 ºC enabling them to easily 
release encapsulated drugs they contain in the human digestive tract.  In addition to gelatin  
possessing the ability to form a gel, they can act as an emulsifier and stabilizers of colloid 
systems.  
 
Figure 1.9. Chemical structure of gelatin. 
1.7.2 Hydroxypropyl methylcellulose (HPMC) 
An alternative to gelatin, hydroxypropyl methylcellulose (HPMC, Figure 1.10) was 
developed in the industry from other polymers in an attempt to replace gelatin due to regulatory 
concerns and drug incompatibility (Al-Tabakha, 2010; Duconseille et al., 2015). HPMC is a 
synthetic modification of the natural polymer cellulose, the most common organic compound 
and biopolymer on earth. HPMC has been used as a thickening agent, as a coating polymer, in 
controlled release systems, and even in solid dispersions to enhance drug solubility (C. L. Li, 
Martini, Ford, & Roberts, 2005). A major defining difference between biopolymers and synthetic 
polymers can be found in their structures.  
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Figure 1.10. Chemical structure of hydroxypropyl methylcellulose (HPMC). Source: Phadtare, 
Phadtare, Nilesh, and Asawat (2014) 
 
1.7.3 Pectin 
Pectin, a biopolymer with stabilizing and gel forming capabilities, is an anionic 
polysaccharide complex of branched heteropolysaccharides from the middle lamella and cell 
walls of plants, consisting of partially esterified galacturonic acid residues, see Figure 1.11 
(Baciu & Jördening, 2004). Pectin for the commercial industry is mainly derived from apple 
pomace and citrus peel, byproducts from juice manufacturing. Even though pectin’s are found 
most commonly in terrestrial plant tissues and cell walls, they do not all possess the ability to 
form gels. The gel forming ability of pectin depends on the molecular weight and the degree of 
methylation (DM) (Thakur, Singh, Handa, & Rao, 1997). The DM is particularly important when 
considering the formulation of a drug delivery system (Ashford, Fell, Attwood, Sharma, & 
Woodhead, 1994), that targets specific sites within the digestive system. Pectins with low 
degrees of methylation (LM pectin), DE < 50%, are relatively soluble but can be cross-linked by 
divalent cations (calcium, Ca) to produce insoluble gels. Conversely, pectins with high degrees 
of methylation (HM pectin), DE > 50%, are poorly soluble, and gel with high concentrations of 
sugar (Löfgren & Hermansson, 2007; Rolin, 1993). Additionally, pectin can be used to 
encapsulate bioactive compounds. 
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Figure 1.11. Structure of pectin. Alpha 1, 4 linked D-galacturonic acid. Source: Ali, El-Regal, 
and Saeed (2015) 
1.7.4 Interactions of protein and polysaccharides  
There are multiple interactions known to occur between proteins and polysaccharides. 
These specific and non-specific interactions cannot be fully understood without prior research, 
and are critical in formulations. Interactions of polysaccharides and protein range from complete 
segregation to complexation (Figure 1.12). Both proteins and polysaccharides are present 
together in many food systems, contributing to the structure, texture, and stability of the food 
independently, through their surface properties and distinctive thickening or gelling behavior. 
Albeit the vast information known at the molecular level about the functionality of individual 
biopolymers, our knowledge of the role of protein-polysaccharide interactions, as it relates to 
their functionality in emulsions, gels or food mixed solutions is somewhat limited. 
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Figure 1.12. Main trends in the behavior or biopolymer mixtures. Source: P. Burey, Bhandari, 
Rutgers, Halley, and Torley (2009). 
Biopolymer interactions in food systems are typically thermodynamically characterized 
by separating them into enthalpy or entropy driven types. Properties of food products, i.e., flow, 
stability, texture, and mouthfeel, are all influenced by protein-polysaccharide interactions in the 
aforementioned thermodynamic categories.  When mixing two biopolymers in solution, one of 
the three possibilities depicted in Figure 1.12 may be observed. The resulting interactions will 
either be segregative or associative. However, in very dilute solutions the proteins and 
polysaccharides are co-soluble. Conversely, upon increasing the concentrations of the 
biopolymers, the co-solubility may be lost. Biopolymer mixtures tend to segregate more often 
than not (de Kruif & Tuinier, 2001).  
The association between protein and polysaccharide molecules can occur chemically 
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through covalent bonds or physically through electrostatic interactions. Attraction and repulsion 
are the two major types of interactions that occur between proteins and polysaccharides in 
solution that may result in complex formations (coacervation), co-solubility or immiscibility of 
the two biopolymers as seen in Fig.  (Benichou, Aserin, & Garti, 2002). The electrostatic 
attraction between pectin and gelatin leads to complexation and coacervation.  
Bungenberg de Jong (1949) first described the formation of coacervates and complex 
coacervates. In general, coacervates are formed reversibly. The word coacervate was used 
because the complex remained liquid, rather than precipitated. This is a phenomenon that occurs 
quite often in biopolymer mixtures in which the biopolymers are oppositely charged.  
 Many polysaccharides carry anionic groups; pectin and gum arabic (GA), for instance, 
carry carboxylic groups. Pectin contains anionic groups (carboxylic groups) in its structure that 
are negatively charged, while other polysaccharides contain phosphate and sulphate groups. 
Gelatin, being an ampholytic protein, can form a complex coacervate with polysaccharides. 
Gelatin being ampholytic means it is anionic at pH > pI and cationic if pH < pI, where pI is the 
iso-electric pH, defined as the pH where the net charge is zero. Gelatin also carries many lysine 
groups and can therefore be used to form complexes with anionic polysaccharides such as pectin. 
A complexation of this type is used in encapsulation. For instance, GA is adsorbed onto an oil–
water interface together with gelatin, thus ‘coating’ the oil droplet with both biopolymers. In this 
way one can use biopolymers as emulsifier although they do not adsorb onto emulsion droplets 
without the other biopolymer.  
Like many other carotenoids, being non-polar and lipid-soluble, the absorption of 
astaxanthin is enhanced with dietary oils (Ambati et al., 2014; Erdman, Bierer, & Gugger, 1993; 
Fernández-García et al., 2012; Parker, 1996). Considering the previously discussed factors 
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affecting the absorption and bioavailability of astaxanthin, it is important to consider a delivery 
system to improve upon those affected processes. The metabolic fate of bioactive compounds in 
vivo does not depend solely on intrinsic factors; however, it is more determined by the carrier 
system. Based on human physiology and the mechanism of lipid absorption, the incorporation of 
such astaxanthin into a delivery system for intestinal uptake and absorption would be beneficial. 
In efforts to overcome the susceptibility of bioactive compounds to a loss of function or 
destruction and improve their stability during processing and storage, emerging technologies of 
nano-/micro-encapsulation are applied in food and nutraceutical industries. Besides protecting 
them from the harsh processing conditions and adverse storage environment, the encapsulations 
of bioactive compounds can also achieve targeted delivery and controlled release of entrapped 
nutrients to the specific site. Encapsulation is a technique employed to create functional foods, 
guaranteeing the stability of functional constituents while allowing their application to diverse 
foods (Dias, Botrel, Fernandes, & Borges, 2017). Encapsulation is a process that creates a barrier 
over the active component that protects against the effect of environmental factors and allows the 
controlled release of the active component under certain conditions. Different delivery systems 
including liposomes, emulsion and complex coacervates, are appropriate to create protective 
barriers. However, complex coacervates, were chosen as the preferred delivery system due to its 
key advantages of heat resistance and a higher loading capacity (Muhoza, Xia, Cai, et al., 2019). 
The controlled release of bioactive compounds is needed to prevent such compounds 
from being completely solubilized and immediately bioavailable following oral ingestion. To 
accompany the immediate release of bioactive compounds after oral ingestion, a characteristic 
pattern featuring high plasma concentrations of the compound shortly after ingestion ensues. 
This is followed by a sharp decrease, as it is expeditiously absorbed into the bloodstream and 
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cleared from the system (Turner et al., 2004).  
Both increased free radical production and reduced antioxidant defenses both lead to 
oxidative stress. Oxidative stress is defined as an imbalance between prooxidants (reactive 
oxygen species (ROS) and other reactive metabolites, i.e. reactive nitrogen species) and their 
elimination by antioxidants, which is in favor of the prooxidants (Reuter, Gupta, Chaturvedi, & 
Aggarwal, 2010; Sies, 2013). As a result of oxidative stress, the production of biomarkers (i.e. 
cytokines, protein carbonyls, and thiobarbituric acid reactive substances relating to lipid 
peroxidation) is increased via several different mechanisms (Elmarakby & Sullivan, 2012; J. Liu 
et al., 2000). The production of cytokines causes a cascade of additional cytokines to be secreted, 
ultimately leading to deleterious effects on the body. Exercise increases rates of oxygen 
consumption by the whole body and tissue causing oxidative stress and tissue damage (J. Liu et 
al., 2000). However, this damaging response is attenuated if exercise is done repeatedly as the 
tissue acclimates to the new overload stress  
Studies suggest the addition of an antioxidant is required to achieve an overall positive 
effect of dietary oils, as it relates to the further oxidation of components within the oil that 
potentially lead to increased oxidative damage and shortening of the lifespan in animal models 
(Tsuduki, Honma, Nakagawa, Ikeda, & Miyazawa, 2011). There is a synergistic effect between 
AX and edible oils, for example AX may offer protection to the oil from oxidation and the oil 
improves the stability and absorption of the AX. Studies have reported that carotenoids are 
absorbed in the body like lipids and undergo the same transport mechanisms as does lipids. 
Nonetheless, flaxseed oil is used to extract AX in order to create a carotenoid rich edible oil 
(FOAX) that can be used in further processing steps to add nutritive value. The extraction of AX 
using (flaxseed oil), to assess the effect of FO and AX together against oxidative stress as well as 
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the synergy between the two, relating to slowing the oxidation of the FO and subsequently 
creating a delivery system with the flaxseed oil (FO) containing AX (FOAX) to investigate the 
transport of astaxanthin for absorption. 
1.8 Cancer trends and treatment 
Cancer, a collection of related diseases, impacts the lives of many people all around the 
world. Cancer, occurring among men and women alike, can start almost anywhere in the body 
(see Table 1.3). Recently it was projected for 2019 that 1,735,350 new cancer cases would occur 
in the United States (Siegel, Miller, & Jemal, 2019). Of those projected new cases, 34.4% are a 
result of patient mortality due to the disease. Cancer is the second leading cause of death 
worldwide. With normal human physiological processes, cells grow and divide to form new cells 
as the body requires. Those new cells take the place of old or damaged cells. Conversely, with 
cancer the body’s cells divide without stopping, regardless of being damaged, and spread into 
surrounding tissues potentially causing tumors.  
Table 1.3. Percentile of the Projected (1,762,450) New Cancer Cases and Survival Rates 
Cancer sites (part) 
% of projected new 
cases % Survival 
Oral  3 79.5 
Breast  15.4 84.4 
Digestive system  18.6  
   Esophagus 1 8.9 
Stomach 1.5 59.5 
 
 
5.8 
 
49.7 
Liver 2.4 24.4 
Pancreas 3.2 19.4 
Respiratory system  13.9  
Lung 12.9 37.4 
Skin  5.9  
Melanoma 5.4 92.5 
(table cont’d) 
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Cancer sites (part)  
% of projected new 
cases % Survival 
Genital system    
Ovaries 1.3 37.9 
Prostate 9.9 81.9 
Brain  1.4 25 
Lymphoma  4.7 74.5 
Leukemia  3.5 63 
Source: Siegel et al. (2019) 
Tumors can be either benign or malignant. As a malignant tumor, capable of spreading 
into or invading neighboring tissues, some of the cancer cells may disassociate and travel to 
other sites in the body through the blood or lymphatic system and form new cancerous tumors 
(metastasizing). On the other hand, benign tumors do not spread or invade adjacent tissues. 
Albeit benign tumors do not grow back after removal, some can be life threatening, like benign 
brain tumors (Hill, Nixon, Ruehmeier, & Wolf, 2002). 
Genes are fragile and a variety of things can damage them, including sunlight and how 
they are copied during proliferation. In chromosomal DNA only 5 to 10 percent of all cancers are 
genetic in origin. According to Glaire and Church (2019), cancer, a disease of a disordered 
genome, is an unregulated, disproportionate division of cells. This is recognized pathologically 
by a greater proportion of cells actively in the cell cycle than is ordinarily present in the normal 
tissue from which it originated. Meaning a higher fraction of cells are in mitosis, recognizable by 
microscopy, and a higher fraction of cells are in S-phase, where DNA replication occurs.  
1.8.1  Breast Cancer 
Of the 100 or so different types of cancer, breast cancer, the most common form of 
cancer in women globally, is the second leading cause of deaths for women in the United States 
(Boyle, 2012). About 12% of women in the United States will develop invasive breast cancer 
over the course of their lifetime (Brocker, 2017; Friedman, 2018; Gemignani, 2016; J. Harrison, 
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2019; Hill et al., 2002). Breast cancer comprises distinct subtypes that have different biological 
and clinical behaviors. Researchers have defined four main classical subtypes of breast cancer 
based on biological and clinical meaningfulness pertaining to how abnormal the cancer cells and 
tissue look microscopically and how quick they are likely to metastasize (Weigelt, Geyer, & 
Reis-Filho, 2010). The subtypes differ by their expression of the estrogen receptor (ER), 
progesterone receptor (PR) and the human epidermal growth factor receptor 2 (HER2 positive) 
(Tyanova et al., 2016).  
ERs are nuclear receptors belonging to the steroid hormone receptor superfamily that 
mediate the effects of the C18 sex steroid, 17ß-estradiol (E2), produced by the testis and ovaries 
in both men and women, respectively (Enmark & Gustafsson, 1999; Hess et al., 1997). E2 has 
primary effects on females during their reproductive and development years, while also playing a 
critical role in male sexual function (Brock, Baum, & Bakker, 2011; Schulster, Bernie, & 
Ramasamy, 2016). Darbre, Yates, Curtis, and King (1983) found that E2 increased the growth 
rate of a human breast cancer cell line that is positive for ER expression. Similarly, a second 
nuclear receptor belonging to the steroid hormone receptor superfamily, known as PR, mediates 
the effects of the C21 sex steroid, progesterone (Scarpin, Graham, Mote, & Clarke, 2009). 
Progesterone is critical for the normal reproductive function of women, and has been shown to 
increase the proliferation of luminal epithelial cells (Clarke, Howell, Potten, & Anderson, 1997; 
Masters, Drife, & Scarisbrick, 1977; Meyer, 1977; Potten et al., 1988). Cells that are ER/PR-
positive are much more likely to respond to hormone therapy than those that are ER/PR-
negative. HER2, a member of the epidermal growth factor family, when overexpressed is 
associated with a more aggressive, decreased survival, and higher recurring form of disease 
(Mitri, Constantine, & O'Regan, 2012). Lastly, there is a subtype known as, triple-negative 
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Figure 1.13. The triple-negative breast cancer (TNBC) cells are so termed because they lack 
expression of the ER, PR, and HER2 receptors. TNBC cells present a poor prognosis and are 
considered to be more aggressive and the most difficult to treat due to there being fewer targeted 
medicines available.  
 
   
Figure 1.13. (A) MDA-MB-231 epithelial cells expressing mesenchymal-like phenotypes (high 
number after 2 days incubation in DMEM at 37 ºC. (B) MDA-MB-231 (ATCC® HTB-26™) 
epithelial cells expressing mesenchymal-like phenotypes. Source: ATCC® (2020) 
1.8.2 Breast cancer treatment 
In the event that cancer develops, the key to successful treatment is early detection. 
Prompt early diagnostic and accessible treatment for cancer is critical for survival (Organization, 
2017). Cancers are treated with a combination of drugs (angiogenesis inhibitors, modulation of 
signaling pathways), chemotherapy (kill or stop proliferation), radiation (kill of stop 
proliferation), and/or surgery (removal of tissue infected with cancerous cells)(Arora & Scholar, 
Mesenchymal-like
AA B 
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2005; Lebert, Lester, Powell, Seal, & McCarthy, 2018).  
Since the dawn on the 21st century, substantial advancements have been made in the 
treatment of hormone responsive tumors and gene amplified subtypes, ER+ and HER2+, 
respectively, with various types of therapies available including monoclonal-antibody based and 
hormonal therapies and small molecule inhibitors of tyrosine kinases for both localized and 
metastatic forms of cancer (L. Chen, Linden, Anderson, & Li, 2014; W. Y. Chen et al., 2004; 
Ma, Bernstein, Pike, & Ursin, 2006; Verkooijen, Bouchardy, Vinh-Hung, Rapiti, & Hartman, 
2009; T. Yoshida et al., 2014). As a result, survival rates of patients diagnosed with the luminal 
or amplified subtypes have improved tremendously, particularly for those cancers detected early. 
However, the distinct phenotypes, molecular profiles, and lack of viable receptors for targeted 
therapy of TNBC result in the ineffectiveness of therapies recommended for other subtypes of 
breast cancer. 
TNBC present a major challenge for oncologist, as they comprise 10-15% of all breast 
cancers diagnosed with limited treatment. This subtype of cancer is more commonly seen in 
young and obese women, with a greater prevalence in premenopausal African American women 
(Fang et al., 2017; Schäfer et al., 2019). Only systemic treatment options, chemotherapy 
combined with standard cytotoxic agents, are available to patients with TNBC.  
However, with systemic treatment options, comes great risks. Cytotoxic agents having a 
narrow therapeutic window combined with the complexity of their pharmacologic profile results 
in a higher risk of experiencing side effects. One problem that may be of subject to scrutiny is 
permanent bone marrow damage associated with cancer treatments (Lohrmann, 1984). While 
chemotherapy is a principal component of treatment for cancer, the damaged induced on healthy 
cells while damaging cancer cells leads to co-morbidity and sometimes mortality (Pearce et al., 
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2017). Most side effects of chemotherapy affect the patient's quality of life, (i.e. appetite loss, 
thrombocytopenia, edema, delirium, diarrhea, constipation, fatigue) and the attempts to manage 
such side effects have decreased survival rates (Abrams et al., 2012; Blauwhoff-Buskermolen et 
al., 2016; Rutten et al., 2016).  
1.8.3 Finding alternative treatment 
Researchers focus on the genome and their RNA transcripts to develop alternative 
therapeutic routines in an effort to decrease the co-morbidity and mortality associate with 
treatment of TNBC. A model of TNBC is the MDA-MB-231 cell line, an immortalized human 
metastatic cell line isolated at The University of Texas MD Anderson Cancer Center from a 
pleural effusion of a patient with invasive ductal carcinoma (Welsh, 2013). MDA-MB-231 cells 
are ER-negative, PR-negative, HER2-negative, and express mutated p53.  
Additionally, the MDA-MB-231 cell line is mesenchymal in phenotype and have 
repressed expression of epithelial (E)-cadherin to facilitate release from the tumor and gain N-
cadherin to attach at distal sites. Cadherins are cell adhesion molecules (CAM) that function to 
bind cells to one another. Neural (N)-cadherin (CDH2), a cell adhesion molecule than can cause 
disassembly and cell migration when inappropriately expressed (Islam, Carey, Wolf, Wheelock, 
& Johnson, 1996). CAMs are important in cancer invasion and metastasis. During embryonic 
development, organ fibrosis and wound healing a biological process takes place where epithelial 
cells convert to a mesenchymal phenotype (Roche, 2018). After such conversion, epithelial cells 
lose their cell polarity and cell-cell adhesion, gaining migratory and invasive properties 
(fibroblast properties). This process is known as an epithelial-to-mesenchymal transition (EMT), 
and the resulting mesenchymal cells are capable of differentiating into a variety of cell types. 
Moreover, EMT is not complete in cancer cells, so they express both epithelial and mesenchymal 
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genes, making them more aggressive than cells with a complete EMT phenotype (Jolly et al., 
2015). In cancer cells, an increase in N-cadherin, disruption of cell-cell adhesion, expression and 
a decrease in C-cadherin are characteristic of EMT.  
Research has focused extensively on methods to inhibit or even reverse the EMT process 
and induce mesenchymal to epithelial transition (MET) to inhibit tumor metastasis. The 
anticancer properties of natural compounds are rapidly gaining interests of many researchers for 
this. Varied classes of natural compounds have demonstrated anticancer properties including 
marine-based bioactive compounds (Fan et al., 2018; Kim, 2014; Simmons, Andrianasolo, 
McPhail, Flatt, & Gerwick, 2005). Carotenoids are associated with numerous health benefits. 
One in particular, shown in many epidemiological studies, is the inverse relationship between 
various cancers and a high intake of carotenoid containing foods (Astorg, 1997; Martí, Roselló, 
& Cebolla-Cornejo, 2016; Ni, Yu, Wang, Zhang, & Shen, 2017; Nishino, Murakoshi, Tokuda, & 
Satomi, 2009; Rowles III & Erdman Jr, 2020). However, the exact mechanisms by which the 
protection is afforded is still under investigation. Furthermore, in addition to their antioxidant 
and provitamin A activity, carotenoids can affect cell growth, regulation, and modulate immune 
and gene expression (Mercke Odeberg et al., 2003). 
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CHAPTER 2  EXTRACTION OF CRAWFISH AND SHRIMP 
ASTAXANTHIN WITH FLAXSEED OIL: EFFECTS ON LIPID 
PEROXIDATION AND ASTAXANTHIN DEGRADATION RATES 
 
2.1 Introduction 
Louisiana is the nation’s leader in production of crawfish (Procambarus clarkii) and in 
shrimp harvesting, whose seasons run from November to July (crawfish) or generally year-round 
(shrimp), and is reported to be the world’s second-largest seafood producer by volume 
(Delcambre, 2018; Simon-Friedt et al., 2016). The crawfish industry of the South Louisiana, 
better known as the crawfish capital of the world, is a multi-million-dollar industry. Louisiana is 
also home to an excess of 90% of the crawfish farms in the United States.  
As a result of crawfish processing (peeling), crawfish processing byproducts (CB) are 
generated containing cephalothorax, abdominal exoskeleton, and viscera, which accounts for 
approximately 85% of the whole crawfish (H.-M. Chen & S. P. Meyers, 1982). The processing 
byproducts generated from crustacean species are a good source of high-quality bioactive 
compounds, i.e. astaxanthin, and there are opportunities to use such processing byproducts to 
extract astaxanthin. Astaxanthin can be used as a natural antioxidant ingredient in foods, feeds, 
and nutraceutical applications. Astaxanthin, the main pigment found in salmonids and crustacean 
species provides the desirable reddish-orange color in many organisms (Additives et al., 2019).  
Additionally, the antioxidant activity of astaxanthin is one of its most important 
properties. It has been reported that the antioxidant activity of astaxanthin is 10 times higher than 
other carotenoids such as zeaxanthin, lutein, canthaxantin, and β-carotene (Miki, 1991; Yuan, 
Du, Jin, & Xu, 2013). Several studies have identified astaxanthin as having antioxidant 
mechanisms that quench active oxygen species and free radicals in vitro and in vivo (Edge and 
others 1997; Palozza and Krinsky 1992; Rengel and others 2000). Due to its antioxidant 
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properties, astaxanthin may have a role in the treatment of chronic diseases such as 
cardiovascular diseases, cataract development, macular degeneration, and cancer (S. T. Mayne, 
1996). 
There has been an ever-growing increase in the potential markets for natural antioxidants 
in soft drinks, ice cream, desserts, candies, meat products and pet and aquaculture feeds 
(Delgado-Vargas and others 2000; Delgado-Vargas and Paredes-Lopez 2003). Although natural 
carotenoids only accounted for 24% of the world market in 2014, they are expected to grow an 
additional 3.9% in response to increasing consumer demands (Joel, 2015). Astaxanthin was 
valued at $512.6 million in 2016, and is predicted to reach $814.1 million by 2022 (Markets, 
2017).  
Astaxanthin can be extracted from crawfish and shrimp processing byproducts using 
solvents or edible oils. H. M. Chen and S. P. Meyers (1982) have extracted astaxanthin from 
crawfish processing byproducts using soybean oil. Since, studies have been done to further 
increase the biological function and stability of astaxanthin by extracting it with a more health 
beneficial edible oil. Astaxanthin has been investigated for its protective effects in flaxseed oil, 
which is used as an extraction solvent (Pu & Sathivel, 2011). An established extraction 
procedure for extracting astaxanthin from crawfish and shrimp processing byproducts was 
developed to microencapsulate flaxseed oil containing astaxanthin (Pu, Bankston, & Sathivel, 
2011a, 2011b).  
Antioxidant-rich natural astaxanthin dispersed in alpha linolenic acid-rich flaxseed oil 
may provide a healthier functional food options for US consumer. Flaxseed oil has high content 
of alpha-linolenic acid (ALA) and linoleic acid (LA) which are precursors to long-chain (n-3) 
fatty acids such as eicosapentaenoic acid (EPA) and 21 docosahexaenoic acid (DHA), 
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respectively (C. Harper, Edwards, DeFilipis, & Jacobson, 2007; Tzang et al., 2009). Both ALA 
and LA are considered to be essential fatty acids and studies have shown that ALA can protect 
against cardiovascular disease and inflammation (Bloedon & Szapary, 2004).  
It is well known that lipid autoxidation of oils mostly depends on the storage temperature 
and storage period (Aidos, Lourenco, Van der Padt, Luten, & Boom, 2002; Tan, Man, Selamat, 
& Yusoff, 2001). H. M. Chen and S. P. Meyers (1982) have reported that the stability of 
astaxanthin is affected by heat, duration of exposure to oxygen, and the intensity of exposure to 
light. Therefore, it is important to consider lipid oxidation and degradation rates of flaxseed oil 
containing astaxanthin, while simultaneously protecting the function and biological activity of 
the astaxanthin.  
The utilization of a novel extraction method to eliminate or reduce the previously 
mentioned factors that negatively impact the function and stability of lipids and bioactive 
compounds, like astaxanthin, is ideal for potentially producing a better product. Ultrasound 
assisted extraction (UAE) technologies are of interest for enhancing the extraction of 
components from plant and animal tissues, although there is limited information on continuous 
UAE. Previously published works on UAE collectively represent several important performance 
increases; reduction in extraction time, increased extraction efficiency, and improved extraction 
with a reduced extraction temperature (Albu, Joyce, Paniwnyk, Lorimer, & Mason, 2004; 
Balachandran, Kentish, Mawson, & Ashokkumar, 2006; Riera et al., 2010; Xia, Shi, & Wan, 
2006). The objectives of this study were to extract astaxanthin from crustacean (i.e., crawfish and 
shrimp) processing byproducts using flaxseed oil and to study the oxidation rates and the 
astaxanthin degradation rates in the flaxseed oil. During the course of this study shrimp 
processing byproducts were investigated as a source of astaxanthin. However, since the amount 
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of astaxanthin recovered from shrimp processing byproducts was considerably less than that 
from crawfish processing byproducts, it was decided to use crawfish processing byproducts for 
subsequent studies. 
2.2 Materials and Methods 
Flaxseed oil was purchased from Whole Foods Market (Baton Rouge, Louisiana). DPPH 
(2,2 diphenyl-1-picryl-hydrazyl-hydrate) and potassium iodide were purchased from Sigma 
Aldrich (USA), and ascorbic acid was purchased from HiMedia Labs (Mumbai, India. All other 
chemicals were obtained commercially and were analytical-grade. 
2.2.1 Sample collection 
The term “crustacean” used here refers crawfish and shrimp, unless specifically stated 
otherwise. Fresh head-on individually quick frozen (IQF) shrimp (Figures 2.1 and 2.2) were 
obtained from a local shrimp processor and transported frozen (Figures 2.3) to the laboratory 
then stored in a freezer until peeled for further analysis and extraction. For analysis, the shrimp 
were peeled to generate shrimp processing byproducts (SB), containing cephalothorax, carapace, 
exoskeleton of the abdomen (including pleopods), and viscera. Fresh farmed crawfish, Figure 
2.4, were used to obtain crawfish processing byproducts (CB), consisting of the entire 
cephalothorax, carapace, exoskeleton of the abdomen, and viscera after parboiling (by producer) 
and removal of the tail meat, Figure 2.5, were obtained from a local Louisiana crawfish producer 
and processor, and transported to the laboratory frozen on ice. Prior to transportation, CB were 
sealed in freezer bags (Figure 2.6) at the processing facility, with minimum headspace, and once 
back at the laboratory placed in a freezer at -20 °C until further analysis and astaxanthin 
extraction. Prior to ultrasound assisted extraction, the frozen CB (-20 °C) were frozen again at -
60 °C, then freeze dried, comminuted using a Magic Bullet® (Capbran Holdings, LLC., Los 
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Angeles, CA), sieved and stored in the freezer at -20 °C until future analysis.  
 
        
Figure 2.1. Vats GOM shrimp at processing facility Figure 2.2. Shrimp being 
emptied into a container for 
removal of debris before 
peeling process. 
       
Figure 2.3. Thawing of IQF shrimp     Figure 2.4. Crawfish farm                      
                                                                  Crowley, LA. 
       
 Figure 2.5. Peeling and                                                           Figure 2.6. Frozen crawfish 
sizing crawfish tails.                                                                                     byproducts (peelings). 
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2.2.2 Determining proximate, moisture and total extractable astaxanthin of crustacean 
processing byproducts 
 
2.2.2.1 Proximate determinations 
Three batches of thawed CB or SB were analyzed to determine ash, protein, and fat 
contents. Two g samples of CB or SB were samples were sent for protein analysis to the SOIL 
sciences lab, where they were analyzed and ashed in a muffle furnace at 550 ºC for 4 h according 
to AOAC method 942.05 (AOAC 1995). The protein was calculated by multiplying total 
nitrogen content by 6.25. Fat content was determined using a Soxhlet extraction method 
according to AOAC method 920.39 (AOAC 1995). 
2.2.2.1 Moisture 
Moisture content of thawed SB, CB, and freeze-dried CB before and after extraction 
procedures was determined using a SMART System 5 microwave moisture analyzer (CEM 
Corporation, Matthews, NC), using a rapid microwave drying method specified in AOAC 
International procedures for moisture analysis of meat and poultry (AOAC Method 985.14) with 
minor modifications, i.e. adjusting time to evaporate moisture from sample to prevent burning 
the sample. The weight loss was determined by electronic balance readings before and after 
drying. 
2.2.2.3 Total extractable astaxanthin in crawfish and shrimp byproducts 
The term “astaxanthin” used here refers astaxanthin and all its esters, which have been 
identified as the main carotenoids in the exoskeleton of heat-processed crustacean. Three batches 
of comminuted crawfish processing byproducts, thawed comminuted shrimp processing 
byproducts, freeze dried comminuted crawfish processing byproducts and freeze dried 
comminuted shrimp processing byproducts were used for the solvent extraction of astaxanthin 
using a method described by Armenta‐López, Guerrero, and Huerta (2002) and H.-M. Chen and 
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S. P. Meyers (1982) with slight modification. The crustacean processing byproducts were placed 
in petroleum ether-acetone-water (15:75:10 v/v/v) overnight then filtered. The filtrate was 
washed with petroleum ether until colorless, and the volume of petroleum ether used was 
recorded. The absorbance for petroleum ether layer containing astaxanthin was measured at 468 
nm (Hong Kyoon No, 1987) using a GENESYS 20 UV-Vis spectrophotometer (Thermo Fisher 
Scientific, Inc., Rochester, NY, USA). The total extractable astaxanthin in 100 g of crustacean 
processing byproducts was calculated using equation 2.1 of Kelley and Harmon (1972) and Pu 
(2010). /0123241ℎ64	869:;	(=> 100	>⁄ B8CDE;FG10) = JKLM	×	O	×	PQKR	×	S %UVW      (2.1) 
where A = absorbance at maximum wavelength (468 nm) in petroleum ether; V is 
volume of petroleum ether (mL); W is weight of crustacean processing byproducts (g); X %UVW is 
extinction coefficient = 2400 in petroleum ether (H. M. Chen & S. P. Meyers, 1982). 
2.2.3 Extraction of astaxanthin from crustacean with flaxseed oil 
 
The effects of pretreatment (freeze-drying, grinding) on the extraction of astaxanthin was 
initially investigated for verification purposes (data not shown). Two treatment methods are 
used: conventional, frozen (-20 ºC) followed by thawing; and frozen (-20 ºC) then frozen (-60 
ºC) followed by subsequent freeze drying. All freeze dried samples were comminuted in a Magic 
Bullet® (Capbran Holdings, LLC., Los Angeles, CA) for one minute, then sieved through a 40-
mesh screen. Retained shells (unpassed through sieve) were reground with additional shells and 
subsequently sieved through a 40-mesh screen, followed by sieving through a 30-mesh sieve. 
Shells passing through the 40-mesh but not the 30-mesh were used.  
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2.2.3.1 Conventional extraction 
For conventional extraction, frozen crawfish processing byproducts were thawed or 
frozen at -60 ºC then freeze dried and used for extraction frozen shrimp were thawed and peeled 
then the shells were used immediately in the extraction process.  Previously. Otherwise CB or 
SB were kept frozen for later use in extraction of astaxanthin.   
Flaxseed oil (FO) containing crawfish astaxanthin (FOCAX) or shrimp astaxanthin 
(FOSAX) was prepared using a method of N. M. Sachindra et al. (2005) with slight 
modifications as described in Figure 2.7. Crawfish or shrimp processing byproducts (100 g) were 
comminuted in a food blender (Magic Bullet®, Capbran Holdings, LLC., Los Angeles, CA), 
Figure 2.8, for 5 min, then combined with an equal amount of flaxseed oil (100 g) in a 500 mL 
amber Pyrex® bottle. After simple mechanical extraction (heating of comminuted crustacean 
processing byproducts/oil mixture 1:1, w/w with constant stirring) for 60 minutes at 60 ºC, 
aliquots (Figure 2.9) of the mixtures were centrifuged at 10,000 x g using a centrifuge (Sorvall 
RC28S, DuPont, Willmington, DE, USA) for 15 min at 4 °C. This was performed to separate 
FOCAX or FOSAX and water phase from the solid phase. The top layer lipid fraction was 
separated manually with a separatory funnel (Figure 2.10) and stored at -20 ºC in a sealed 
container that limits the transmittance of light at -20 °C for later analysis.  
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Figure 2.7. Conventional extraction of astaxanthin from crustacean processing byproducts 
using flaxseed oil. FOCAX = Flaxseed oil containing crawfish astaxanthin. FOSAX = 
Flaxseed oil containing shrimp astaxanthin.  
 
             
Figure 2.8. Shrimp processing           Figure 2.9. Centrifuge bottle 
byproducts.              containing flaxseed oil with astaxanthin 
      
Peeled crawfish or 
whole shrimp
Crawfish minced meat 
or peeled shrimp
Crawfish/shrimp (head, 
body, carapace)
Comminuted 
crawfish/shrimp 
byproducts
Extraction of 
astaxanthin
Centrifugation
Solid phase FOCAX/FOSAX and water
Separatory 
funnel
FOCAX/FOSAX
Water
FO
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Figure 2.10. Phase separation using    Figure 2.11. Freeze dried crawfish 
a separatory funnel      processing byproducts. 
 
2.2.3.2 Novel extraction: combined ethanol, flaxseed oil, and ultrasound assisted extraction 
of astaxanthin from crawfish processing byproducts 
 
The extraction of AX from crawfish processing byproducts followed a similar procedure 
as that described in section 2.2.3.1. for crawfish with slight modifications. The crawfish 
processing byproducts were collected from Bocage Crawfish, LLC (Figure 2.6). These CB were 
frozen and placed on ice then were transported to the laboratory. The frozen CB was frozen at -
60 °C before being freeze-dried, comminuted and sieved (40 mesh). The freeze-dried CB 
particles were stored in a freezer at -20° C in a 500 mL amber Pyrex bottle. A continuous ultra-
sonication system was used to provide sonication treatments for releasing AX from the 
crustacean processing byproducts. The system consisted of an ultrasonic processor (Model CPX 
500, Cole Palmer Instruments, Vernon Hills, IL, USA) with an ultrasonic probe of 13 mm 
diameter and an ultrasonic converter for producing sonic waves at a frequency of 20 kHz (Figure 
2.10). 
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Figure 2.12. Ultrasound assisted extraction system used to extract astaxanthin. 
The continuous system was established using a double wall stainless steel cylindrical 
processing chamber, also called a continuous flow cell (Figure 2.10) which was screwed onto the 
threaded portion of the ½ inch Ti alloy (Ti-6Al-4V) ultrasonic horn. Freeze-dried comminuted 
CB (25 g) was placed in the flow cell for AX extraction. The mixture of flaxseed oil with 200 
mL of ethanol (1:8), was pumped at the rate of 24 mL/min using a peristaltic pump (Master Flex 
L/S, Cole Palmer, Vernon Hills, Il, USA) through the collection bottle to the continuous flow 
cell was CB were sonicated at 40% amplitude by the ultrasonic processor for 20 minutes. 
Ethanol was selected as a continuous co-solvent for extraction due to its GRAS status 
(Montanari, Fantozzi, Snyder, & King, 1999). A control sample was prepared by passing only 
flaxseed oil or only ethanol through the flow cell containing CB without sonication at a rate of 
24 mL/min. Prior to the experiment the continuous flow cell was sanitized using 200 ppm 
solution of sodium hypochlorite (Sigma-Aldrich co., St Louis, MO, USA), followed by rinsing 
with distilled water to remove residual sanitizer. The temperature of all the samples was 
maintained at <25 °C during sonication using a simple chilling method with dry ice. After 
A. Ultrasonic processor 
B. Ultrasonic convertor 
C. Processing chamber 
D. Ultrasonic horn 
E. Cooling system 
F. Peristaltic pump with controller 
G. Amber bottle collect extract 
B 
C 
D 
E 
F 
G 
A 
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extraction, the crude extracts were vacuum filtered with BUCHI/Whatmann paper #1, 3 times in 
a dark room, to remove solid particles. The FO containing AX from ethanol and UAE 
(FOCAXUAE) was concentrated by rotary evaporation to remove residual ethanol and stored in 
a dark space for immediate analysis. If analyses were to be performed at a later time, samples F 
were stored in Eppendorf tubes that restrict the passage of light and stored in the freezer at -20 
°C until analysis. 
2.2.4 Density, specific gravity, water activity, and moisture content of FO, FOCAX, 
FOSAX and flaxseed oil containing crawfish astaxanthin from ethanol and 
ultrasound assisted extraction  
 
The density (r) of the FO, FOCAX, FOSAX, and FOCAXUAE was determined in 
triplicate using a 10 mL glass-graduated cylinder at 25 °C. The sample was filled to 10 mL, the 
mass (g) to volume (mL) ratio determined, and density values (r = m/V) were reported as grams 
per milliliter. Specific gravity of the flaxseed oil, FOCAX, FOSAX, and FOCAXUAE samples 
was determined in triplicate using a 25 mL glass-measuring cylinder. The net weight of the oil 
sample (g) was divided by the net weight of the same volume of water (g) at 25 °C to obtain the 
specific gravity. A calibrated water activity (aw) meter (AquaLab Pawkit, Decagon Devices Inc., 
Pullman, WA) was used to measure the water activity of flaxseed oil, FOCAX, FOSAX and 
FOCAXUAE at 25°C. The moisture content was measured according to the Karl Fischer titration 
method, AOCS Official Method Ca 2e-84, using a Mitsubishi Karl Fischer Moisturemeter 
(Mitsubishi Chemical Analytech Co., Ltd., Japan).  The sample amount size was 0.3 – 0.35 g for 
FO and 0.25 – 0.36 g for FOCAX, FOSAX, FOCAXUAE. 
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2.2.5 Measurement of astaxanthin in FOCAX, FOSAX and FOCAXUAE samples.  
2.2.5.1 Conventionally extracted astaxanthin concentration 
The amount of astaxanthin in the FOCAX and FOSAX was determined 
spectrophotometrically at 500 nm wavelength as described by Chen and Meyers (1984). The 
astaxanthin extracted from the processing waste was quantified using Equation 2.2. of Kelley 
and Harmon (1972) with slight modifications, and reported as mg astaxanthin/100 g flaxseed oil 
(FO): /0123241ℎ64	(=> 100>⁄ Y%/Z) = J[\\		]	×	PQ^_	×	`	×	SUab% 	          (2.2) 
where A is absorbance at 500 nm; D is dilution factor, d is the cell width (1 cm); S = 
0.92, specific gravity of flaxseed oil; X %UVW is extinction coefficient = 1827 in flaxseed oil (Pu et 
al., 2010); FOAX is flaxseed oil containing crustacean astaxanthin. 
2.2.5.2 Combined ethanol, flaxseed oil ultrasound assisted extracted astaxanthin 
concentration 
 
Astaxanthin concentration (AXC) in the #UAE oil samples was determined according 
to the method of Saito and Regier (1971) with a slight modification. Oil (30 mg) was mixed with 
10 ml of petroleum ether and the mixture was allowed to stand for 30 min. The absorbance of oil, 
appropriately diluted, was measured at 468 nm using a GENESYS 20 UV-Vis spectrophotometer 
(Thermo Fisher Scientific, Inc., Rochester, NY, USA). The concentration (C) of astaxanthin in 
the sample was calculated using Equation 2.3: /0123241ℎ64	(c> >⁄ flaxseed	oil) = JKLM	×	+mnopq	mr	smnotumv		×	_unotumv	rwxtmyQ."	×	zqu{*t	mr	swp|nq	osq_	({)                   (2.3) 
where 0.2 is the A468 of 1 μg/ml standard astaxanthin, 10 is the volume of solution in 
milliliters, and 1 is the dilution factor of solution. 
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2.2.6 Measurement of color for CB, SB, FO, FOCAX, FOSAX, and UAE oils. 
The color of CB, SB, FO, FOCAX, FOSAX, and UAE oils were measured in triplicate 
using a HunterLab LabScan XE benchtop spectrophotometer (Hunter Associates Laboratory, 
INC. Resbon, VA) and was reported in CIELAB color scales (L*, a* and b* values). The 
instrument was standardized using the calibrated black and white standards that come with the 
instrument. Three grams of flaxseed oil or flaxseed oil with astaxanthin were placed in 1.62 x 
1.62 x 0.312 in. polystyrene weighing dish and weighed. Five polystyrene weighing dishes were 
stacked together to prevent disturbances for the black base. Chroma, hue angle, and color 
difference (DE) values were calculated using Equations (2.4), (2.5) and (2.6), respectively.  
Chroma = [a*2 + b*2] 1/2          (2.4) 
Hue angle = tan-1 (b*/a*)        (2.5)  ∆Xw~∗ = Ä(Å"∗ − ÅP∗ )" + (2"∗ − 2P∗)" + (B"∗ − BP∗)"     (2.6) 
(Pagliarini, Vernile, & Peri, 1990)    
Where L*, a*, and b* are the degree of lightness to darkness, redness to greenness, and 
yellowness to blueness, respectively. Negative Hunter a* values and negative Hunter b* are 
converted to positive values for analysis by adding 180º to the arc tangent after conversion to 
degrees or 360º to the arc tangent after conversion to degrees, respectively, for calculating the 
proper hue based on the appropriate quadrant (McLellan, Lind, & Kime, 1995). 
2.2.7 Measurement of Lipid Oxidation. 
2.2.7.1 Peroxide value 
Measurement of peroxide values (POV), lipid hydroperoxides, in FO, FOCAX, FOSAX 
and FOCAXUAE were determined by two titrimetric methods. For FO, FOCAX, and FOSAX 
samples, the POV were determined as described by Shantha and Decker (1994) using the 
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International Dairy Federation (IDF) standard method 74A:1991 with slight modifications. POV 
measures the transient products of oxidation when peroxides form and breakdown, like 
hydroperoxides formed during the initial stages of lipid oxidation, with high values translating to 
the instability of an oil during storage. To prepare the iron (II) chloride solution, 0.4 g barium 
chloride dihydrate was dissolved in 50 mL water. The solution was added slowly while stirring 
to an iron (II) sulfate solution (0.5 g FeSO4*7H2O dissolved in 50mL water). Then two milliliters 
of 10N hydrochloric acid was added and the barium sulfate precipitate was filtered off to give a 
clear iron (II) solution, which was stored in the dark in brown bottles. Thirty grams of 
ammonium thiocyanate was dissolved in distilled water in an Erlenmeyer flask and brought to 
volume (100 mL). Peroxide values were calculated as follows:  Ñ9DE36;9	Ö2:F9 = 	 (Üá&	Üà)	×	pââ.äã×p\×"        (2.7) 
Where /s = absorbance of the sample at 500 nm; /~ = absorbance of the blank 
containing all the reagents except the sample at 500 nm; = = 41.52 (Shantha & Decker, 1994). 
The second titrimetric method for determining peroxide value is ideal for small-scale 
samples. For the UAE samples, the POV was determined in triplicate in accordance with a 
method of Crowe and White (2001) for small oil samples with slight modifications. An acetic 
acid-chloroform solution (3:2, v/v) was prepared. A saturated potassium iodide (KI) solution was 
also prepared by dissolving excess KI in previously boiled distilled water (about 25.0-gram KI in 
15.0 mL water). The solution was stored in the dark when not in use. A 0.001 N sodium 
thiosulfate (Na2S2O3) solution was prepared by diluting a 0.1 N Na2S2O3 stock (4.962 g Na2S2O 
dissolved in distilled water, and brought to 200 mL) 100-fold. Then 50 µL iron (II) solution was 
added and mixed for 3-4 s. After 5 min incubation at room temperature, the absorbance of the 
sample (FOCAXUAE) was measured at 500 nm against a blank that contained all reagents but 
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the sample by using the spectrophotometer. This was conducted under dim light and completed 
within 10 minutes. The POV, expressed as millimoles of peroxide (==E:	%""&) per kilogram of 
sample, was calculated using the following formula: Ñ9DE36;9	Ö2:F9 = 	 (`&å)×ç×PQQQpwss	mr	swp|nq,{        (2.8) 
2.2.7.2 Thiobarbituric acid-reactive substances (TBARS) analysis of FO, FOCAX, FOSAX, 
and UAE extractions 
 
TBARS content of FO, FOCAX, FOSAX, and all FOCAXUAE (50UAE0, 25UAE, and 
10UAE) sample were measured using methods described by Mei, McClements, Wu, and Decker 
(1998) and Lemon (1975) with modifications. TBA (thiobarbituric acid) solutions were prepared 
by mixing 15 g of trichloroacetic acid, 0.375 g of TBA reagent, 1.76 mL of 12 N HCl, and 82.9 
mL of distilled H2O. Every 100 mL of TBA solution was mixed with 3 mL of 2% butylated 
hydroxytoluene in ethanol. A 0.1 g sample of oil was added to 0.4 ml of water then combined 
with 2.5 ml of TBA solution in a 15 ml capped glass tube vortexed and placed in boiling water 
(95-100 °C) for 15 min. After cooling to room temperature, the mixture was centrifuged at 1163 
× g for 25 min using a benchtop centrifuge (Compact II Centrifuge, Becton-Dickinson, 
Rutherford, New Jersey, USA) and absorbance was measured at 532 nm. TBA values were 
calculated from a standard curve prepared using TEP (1,1,3,3-tetraethoxypropane) standard and 
expressed as mg malondialdehyde (MDA) kg-1oil.   
2.2.8 Studies on oxidative stability of FO, FOCAX, FOSAX, and FOCAXUAE 
A modified method of Ragnarsson and Labuza (1977) was employed to evaluate the 
ability of astaxanthin as an antioxidant to protect flaxseed oil from detrimental effects of elevated 
temperature over time. One hundred twenty-five mL amber Erlenmeyer flasks containing 50±2 g 
of oil samples each was used. The flasks were placed in a water bath at 65 °C to model 
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accelerated shelf life (ASL), while other amber flasks containing oil samples, were not exposed 
to heat, and placed at room temperature 25±0.2 °C. An oil sample was taken from the amber 
flasks using a pipette every hour from 0 to 4 hours for POV. A plot of POV versus time was 
constructed for 65 °C. The resultant straight line yielded the of oxidation rate (=Xè	%""&·kg oil-
1·h-1) at 65 °C.  
2.2.9 Free fatty acids of FO, FOCAX, FOSAX, and FOCAXUAE 
Free fatty acid (FFA) content was determined in triplicate for each sample according to a 
titrimetric method of Ke, Woyewoda, Regier, and Ackman (1976) with slight modification. One 
g samples of oil before and after extracting AX was placed using a dropper and weighed (±0.005 
g) on an analytical benchtop scale in an Erlenmeyer flask and 75 mL of ternary solvents 
(Chloroform, Methanol, Isopropyl Alcohol; 2:1:2) were added, followed by 4 drops of meta-
cresol purple (MCP) indicator solution. As the sample was being mixed on a stir plate, the FFAs 
were titrated to the purple endpoint with 0.05 N NaOH using a burette. The blank was ternary 
solvents and MCP. The percentage of FFA was expressed as oleic acid equivalents using the 
equation described by Ke et al. (1976).  YY/	20	%	E:96G = 	 (ê&å)×P.ãP`         (2.9) 
Where T and B are the volume (ml) of 0.05 N NaOH used to titrate the sample and the 
blank, respectively, and S is the weight (g) of sample. 
2.2.10 Vitamin C equivalent antioxidant capacity (VCEAC) of FO, FOCAX, FOSAX, and 
FOCAXUAE samples in scavenging DPPH (2,2 diphenyl-1-picryl-hydrazyl-hydrate) 
radical, a spectrophotometric assay 
 
The radical-scavenging activity of ethanolic ultrasound-assisted extracted AX in FO was 
assayed following a method described by Rao, Sarada, and Ravishankar (2007) with some 
modifications. A stable free radical, DPPH (2, 2-diphenyl-1-picryl-hydrazyl), was used to 
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evaluate the free radical scavenging capability of FO, FOCAX, FOSAX, and FOCAXUAE 
samples. DPPH reagent (2.36 mg) was dissolved in 100 mL of ethanol in an Erlenmeyer flask, in 
the dark, with 10 min sonication to ensure complete solubilization in the dark. The ethanolic 
DPPH solution (60 µM) was kept in the dark. One mL of the DPPH solution added to 3 mL of 
FO, FOCAX, FOSAX, and FOCAXUAE extracts. The percent of DPPH radical-scavenging 
activity, or inhibition, was calculated as: ëÑÑ'	0G2Ö94>64>	2G16Ö618	(%) = Üaíìîïíñ&(Üáóbòñô&	Üáóbòñô	àñóìö)Üxmvtymn 	× 	100  (2.10) 
where Acontrol, Asample, and Asample blank are the absorbance of the DPPH solution (1.0 mL: 
60 uM) plus ethanol, astaxanthin solution with DPPH (different concentration) and astaxanthin 
solution containing ethanol without DPPH, respectively. The absorbance measurements were 
taken at 517 nm. 
2.2.11 Preparation of standard curve for the absorbance of DPPH against 
A Vitamin C (ascorbic acid) calibration curve that relates the concentration of vitamin C 
and the amount of absorbance reduction caused by vitamin C were obtained using the DPPH 
assay. In order to express DPPH radical scavenging results as mg Vitamin C L-1 oil a calibration 
curve was prepared using 0.1 mL ethanolic solutions of ascorbic acid in the range 0–113.5 mM 
or 20 mg. The linearity was found up to 113.5 mM concentration of ascorbic acid and a line was 
calculated (Figure 2.11). The absorbance at 0-30 minutes of incubation with DPPH radical 
(2.4 mL) was recorded. The absorbance reduction was measured at 517 nm for the astaxanthin 
extracts (FO, FOSAX, FOCAX, and FOCAXUAE against the various concentrations DPPH 
radical to then determine the VCEAC equivalent of each extract. 
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Figure 2.13. Calibration curve using ascorbic acid. 
Calibration curves of absorbance reduction of DPPH radicals versus vitamin C 
concentration were generated. The decreasing absorbances at 517 nm for DPPH radical 
scavenging activity by FO, FOCAX, FOSAX, and FOCAXUAE were measured at various 
concentrations. The results were converted into VCEAC (Vitamin C equivalent antioxidant 
capacity) using the vitamin C calibration curve. The scavenging activities of tested compounds 
against DPPH radicals were calculated as VCEAC in mg/100 ml. 
Ascorbic acid was dissolved in ethanol to make 0 – 20 mg 100 ml-1 concentrations and 
plotted vs. absorbance at 517 nm. Samples were prepared in triplicate. 
2.2.12 Statistical analysis 
Mean values and standard deviations of triplicate reproducible analyses are reported. The 
statistical significance of observed differences among treatment means was evaluated by analysis 
of variance (ANOVA) was carried out to determine the difference among treatment means with 
SAS software Version 9.4 (SAS Institute Inc., Cary, NC) using a post hoc Tukey's studentized 
range test (SAS, 2013) at a significance level of 0.05. 
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2.3 Results and Discussion  
2.3.1 Proximate compositions and total extractable astaxanthin of crustacean processing 
byproducts. 
 
Moisture content (wet weight basis, wwb) of crawfish and shrimp and crawfish 
processing byproducts was 53.69±0.1% and 74.82±0.02%, respectively. The moisture content 
(dry byproducts, db) of crawfish and shrimp processing byproducts was 2.92±0.01% and 
3.19±0.03, respectively. The moisture content (wwb) for thawed shrimp processing byproducts is 
higher, but for thawed crawfish processing byproducts is similar to that reported in previous 
works by Pu (2010), 62.82% and 54.68%, respectively. Furthermore, the moisture content of the 
produced solid waste after conventional extraction of astaxanthin from crawfish and shrimp, was 
57.69% and 60.04 %, respectively, while after UAE extraction of AX from crawfish processing 
byproducts their moisture content was 46.31 %. The values from conventionally extracted 
crustacean byproducts were higher than those reported by Pu (2010) for shrimp, 62.82 %, and 
crawfish, 54.68 %. 
Ash, fat, and protein contents (db) of crawfish processing byproducts before extraction 
were, 40.76±0.05 %, 6.6±0.06 %, and 37.93±0.2 %, respectively (Table 2.1). The ash content 
was within 5 % of values reported by authors in other works, 42.97% (Pu, 2010) and 35.7 % 
(Meyers & Bligh, 1981). However, the fat content was very close to that other authors reported, 
6.7 % (Meyers & Bligh, 1981). The total ash, fat, and protein contents for the shrimp processing 
byproducts accounts for 88.29 %, resulting in the remaining 14.71 % possibly being chitin. 
Ash, fat, and protein contents (db) of shrimp processing byproducts before extraction 
were 18.14±0.68 %, 7.93±0.33 %, and 57.1±0.57 %, respectively (Table 2.1). Previously 
reported ash, fat, and protein content values were, 17.41%, 7.22%, 60.2%, respectively, and 
22.2%, 22.7%, and 51.3%, respectively (Lee and others, 1999). The proximate composition of 
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shrimp processing byproducts varies, depending on their age, diets, species or native habitats, 
which depend on the season (N. M. Sachindra et al., 2007; Yanar, Çelik, & Yanar, 2004). The 
total ash, fat, and protein contents for the shrimp processing byproducts accounts for 83.17 %, 
resulting in the remaining 16.83 % potentially being chitin. 
Astaxanthin being lipophilic, is solubilized in lipids. Therefore, the quantification of 
astaxanthin can be approached from a comparable assessment to extracting lipids with solvents. 
Likewise, extraction was performed to measure the total amount of extractable astaxanthin in the 
crawfish (thawed) processing byproducts, shrimp (thawed) processing byproducts, 
crawfish (freeze dried) processing byproducts, and shrimp (freeze dried) processing byproducts. 
The result was 8.53±0.15 mg 100 g−1 waste, 13.83±0.31 mg 100 g−1 waste, 10.21±0.04 
mg 100 g−1, and 18.68±0.04 mg 100 g−1 freeze-dried waste, respectively. The total AX content 
for wet but not freeze-dried crawfish was slightly lower than that extracted using the same 
solvents, petroleum ether-acetone-water mixture, to extract astaxanthin from crawfish waste, 
15.3 mg of astaxanthin 100 g-1 of crawfish processing byproducts (Meyers & Bligh, 1981). After 
comparing the total extractable astaxanthin data, it was determined that crawfish processing 
byproducts would be used for all subsequent studies. 
2.3.2 Physicochemical characteristics and astaxanthin content of FO, FOCAX, FOSAX, 
and FOCAXUAE 
 
The FO, FOCAX, FOSAX, and FOCAXUAE densities (g/mL) were 0.91±0.00, 
0.92±0.07, 0.92±0.02 and 0.91±0.03, respectively (see Table 2.2), which was a little higher than 
values reported by Sathivel (2005) for red salmon oil (0.9 g/mL) and pink salmon oil (0.81 
g/mL). Specific gravities of the FO, FOCAX, FOSAX, and FOCAXUAE were 0.92±0.00 at 
room temperature. The moisture contents of the FO, FOCAX, and FOSAX were 0.15±0.00%, 
0.17±0.03%, 0.17±0.05%, while in FOCAXUAE the moisture content was 0.15±0.03%. The 
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water activity of FO (0.51±0.0), FOCAX (0.52±0.0), FOSAX (0.52±0.0), and UAEAX 
(0.51±0.7) was slightly lower than other values reported by Sathivel (2005) for red salmon oil 
(0.57) and pink salmon oil (0.53). Moisture in oil increases the FFA content of the oil by lipid 
hydrolysis reactions (Bhattacharya and others 2008). Water contributes to the hydrolysis of oil 
during various handling and processing steps, which generate free fatty acids and glycerol 
products that decrease the oxidative stability of oils (Bhattacharya, Sajilata, Tiwari, & Singhal, 
2008; Choo, Birch, & Dufour, 2007b). FFA content is an intrinsic factor that impacts oxidative 
stability and shelf-life of oils. Therefore, it is most desired to have an oil with a low aw value.  
For conventional extraction using FO, the astaxanthin concentration (AXC) in FOCAX 
(1:1, CB: oil), FOSAX (1:1, SB: oil) and the FOCAXUAE (1:1:8, 25g CB: 25g oil: 200g 
ethanol) per gram of flaxseed oil were, 0.054 mg g−1, 0.092 mg g−1 , and 1.9 mg g−1, respectively 
(Table 2.3), which are similar to values previously reported in the literature for shrimp 
processing byproducts, 0.049 mg g-1 dry waste by De Holanda and Netto (2006) and  (De 
Holanda & Netto, 2006; Handayani, Indraswati, & Ismadji, 2008) and crawfish processing 
byproducts (Meyers & Bligh, 1981). Conversely, the values were greater than those reported by 
Pu (2010) for crawfish and shrimp, 0.0884 mg g−1 wet CB and 0.0647 mg g−1 wet SB, 
respectively. The conventionally extraction technique used here was similar to that of Pu (2010) 
with slight modification. Key differences to highlight include pre-treatments applied like 
comminuting and freeze-drying.  In a previous investigation, De Holanda and Netto (2006) used 
an enzymatic method to extract astaxanthin from shrimp (Xiphopenaeus kroyeri) processing 
byproducts using soy oil and extracted 4.90 mg astaxanthin 100 g−1 processing byproducts. The 
amount of conventionally extracted astaxanthin in both FOCAX and FOSAX was greater than 
that in other vegetable oils such as sunflower oil, groundnut oil, coconut oil, and rice bran 
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oil obtained by N. Sachindra and Mahendrakar (2005). Meyers and Bligh (1981) reported a 10-
fold increase in astaxanthin concentration with vacuumed dried shrimp processing byproducts 
(0.100 mg/g) compared to heat dried shrimp processing byproducts (0.010 mg/g). H.-M. Chen 
and S. P. Meyers (1982) compared the astaxanthin recovery between heat processed CB (0.1615 
mg/g) and unprocessed (not heat processed) CB (0.0878 mg/g) using standard organic solvents 
for extraction. They found that pretreatment with a sonifier and particle size reduction 
contributed to the increase in recovery. Still, the amount of conventionally extracted astaxanthin 
from crawfish (FOCAX) and FOCAXUAE in this study was greater than that obtained by Chen 
and Meyers. 
The amount of astaxanthin recovered by UAE ratios were 0.8 mg g−1 lipid, 1.9 mg 1 g−1 
lipid, and 0.9 mg g−1 lipid, for ratios CB:FO to ethanol (E) 1:1:4 (A), 1:1:8 (B), and 1:1:20 (C), 
respectively. While the amount of astaxanthin recovered by conventional extraction were, 0.054 
mg g−1 FO (FOSAX), 0.092 mg g−1 FO (FOCAX). Both CFO, 0.1 mg g−1, or NFO, 0.2 mg. g−1, 
alone yielded lower extractions of AX than did the combination of the two within the closed 
system. Although, the extraction yields were still greater than the conventional method of 
extraction with regard to the amount flaxseed oil and crustacean byproducts used.  
Numerous studies have revealed that the yield of astaxanthin depends upon many factors; 
such as the extraction methods, the solvents or media used for extraction, and other factors such 
as particle size of the waste and ratio of waste to oil used for extracting astaxanthin from 
crustacean processing byproducts (Praveenkumar, Lee, Lee, & Oh, 2015; N. Sachindra et al., 
2006). However, for UAE, ethanol (E) was combined with the flaxseed oil to extract astaxanthin, 
which explains why FOCAXUAE had a higher concentration of astaxanthin than FOCAX and 
FOSAX. E was chosen as a co-solvent for the ultrasound-assisted extraction of AX, and was 
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previously shown to be the best solvent for extracting AX (Bi, Tian, Zhou, & Row, 2010). 
Ethanol, a very polar short chain alcohol lacks FDA regulatory problems, unlike many other 
solvents. It is the least toxic of the alcohols and is suitable for use in industry and consumer 
products. Previous studies also give supporting data for greater extraction yields of astaxanthin 
obtained when organic solvents were used (Ali-Nehari, Kim, Lee, Lee, & Chun, 2012; Reyes, 
Mendiola, Ibanez, & del Valle, 2014). The differences in extractions of AX could be attributed to 
the additional reduction in the moisture content of the CB by E. Polar solvents (i.e., ethanol) will 
help remove the water in the solid matrix making the less polar pigment (i.e., astaxanthin) more 
available for extraction in non-polar solvents (N. Sachindra et al., 2006).  
Table 2.1. Proximate compositions and AX content of CB, SB, freeze-dried CB, and freeze-dried 
SB. 
Treatment 
Astaxanthin                
(mg g-100 
byproducts) 
% Moisture 
(wwb) 
% Moisture 
(db) Ash % Fat % Protein % 
SSBW 8.53±0.15A 74.82±0.02A  18.14±0.68A 7.93±0.22A 57.1±0.57A 
SCBW 13.83±0.31B 53.69±0.01A  40.76±0.05B 6.6±0.06A 37.93±0.2B 
SFDSB 10.21±0.04 D  3.19±0.02A    
SFDCB 18.68±0.04C  2.92±0.01A    
Note: Values are means ± SD of triplicate determinations. SSBW = Solvent extraction of 100 g 
thawed shrimp processing byproducts; SCBW = Solvent extraction of 100 g thawed crawfish 
processing byproducts; SFDSB = Solvent extraction of 100 g freeze dried shrimp processing 
byproducts SFDCB = Solvent extraction of 100 g freeze dried crawfish processing byproducts.1 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 For SFDSB and SFDCB, the ash, fat, and protein data are not shown because the determinates would not differ. 
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Table 2.2. Physicochemical properties of FO, FOCAX, FOSAX, and FOCAXUAE.  
 FO FOSAX FOCAX FOCAXUAE 
Density 0.91±0.00 A 0.92±0.07 A 0.92±0.02 A 0.91±0.03 A 
S.G. 0.92±0.00 A 0.92±0.00 A 0.92±0.00 A 0.92±0.00 A   
Moisture % 0.15±0.00 A 0.17±0.03 B 0.17±0.05 B 0.15±0.03 A 
Note: Values are means ± SD triplicate determinations. Values not containing the same letters 
in the same row are significantly different (P<0.05). FO = Flaxseed oil; FOCAX = Flaxseed oil 
containing crawfish astaxanthin from conventional extraction; FOSAX = Flaxseed oil 
containing shrimp astaxanthin from conventional extraction; FOCAXUAE = Flaxseed Oil 
Containing Crawfish Astaxanthin From Ethanol and Ultrasound Assisted Extraction. S.G. = 
specific gravity.  
Table 2.3. AXC, POV and TBARS of FO, FOSAX, FOCAX, 10UAE, 25UAE and 50UAE 
with FOAX, NFO and CFO.  
Treatment AXC (mg g-1 oil) POV (mmol O2 . kg-1) TBARS (mg MDA. kg-1) FFA 
FOSAX* 0.054±0.403E 1.84±0.05 A 1.49±0.02 F   2.85±0.01 D 
FOCAX* 0.092±0.912C 1.64±0.09 A 1.39±0.07 E   2.17±0.03 B 
UTCB** 2.1±1.34e-4D 1.35±0.83B 2.38±0.01A 2.13±0.06 B 
UTO (FO) NA 1.27±0.55B 2.09±0.04A   1.57±0.01 C 
50UAE** 0.8±1.86e-5B 1.75±1.61C 1.95±0.00C 2.01±0.01 A 
25UAE** 1.9±2.44e-4A 1.59±0.33A 1.77±0.55B 1.96±0.04 A 
10UAE** 0.9±3.41e-5B 1.35±0.60B 1.55±0.03D 1.94±0.11 A 
NFO** 0.2±1.74e-6C 2.49±1.04B 2.09±0.03A  
CFO** 0.1±9.58e-6C 4.21±1.11B 2.11±0.03E 2.48±0.94 C 
Values are means of triplicate determinations. A-E Means ± SD containing the same letters in the 
same column are not significantly different (P<0.05). AXC = Astaxanthin concentration. POV = 
Peroxide value after the 60-minute conventional extraction time or 20-minute UAE time; 
TBARS = Thiobarbituric acid reactive substances. FFA = Free fatty acids. FOCAX = Flaxseed 
oil containing crawfish astaxanthin from conventional extraction; FOSAX = Flaxseed oil 
containing shrimp astaxanthin from conventional extraction; FO = Flaxseed oil; CB = crawfish 
processing byproducts; UAE = ultrasound-assisted extraction with ethanol; 50UAE = 50 g CB 
with 50 g FO, 25UAE = 25 g CB with 25 g FO, 10UAE = 10 g CB with 10 g FO; UTCB = Non-
UAE oil with ethanol 25 g CB; UTO = Non-UAE oil with ethanol without CB; NFO = EtOH 
only with 25 g CB; CFO = Just FO only with 25 g CB; For NFO, 3g of flaxseed oil used for 
quantitative measurement of AX and oxidative stability. * denotes POV determined by IDF 
74A:1991 method. ** denotes POV determined by method of Crowe and White (2001).  
 
2.3.3 Color evaluation of FO, FOCAX, FOSAX, and FOCAXUAE 
All color values (L*, a*, b*, chroma, hue angle, DE) of CB and SB before and after 
extraction, as well as FO, FOCAX, FOSAX and FOCAXUAE are shown in Table 2.4. The L* 
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value is a measure of the lightness (0-100), while a* and b* values are the measurement of 
redness (more +) and yellowness (more +), respectively. The L* values of all the oil-based 
samples are slightly darker (FOCAX = 45.74; FOSAX = 48.57; 10UAE = 31.17; 25UAE = 
39.39; 50UAE = 41.87) in color than FO, 49.02 and HFO = 52.32. Conversely, the a* values of 
all the oil-based samples were determined to have more redness (FOCAX = 11.34; FOSAX = 
8.84; 10UAE = 33.61; 25UAE = 39.76; 50UAE = 30.89) in color than FO, 1.88.  The b* values 
of all the oil-based samples were determined to have less yellowness (FOCAX = 64.68; FOSAX 
= 73.08; 10UAE = 60.07; 25UAE = 65.35; 50UAE = 53.98) than FO, 77.34.  As it relates to 
color measurements for the crustacean processing byproducts, the color values of L*, a* and b* 
are representative of the extraction processes. The SB before extraction had L*, a* and b* values 
of, 60.71, 0.15 and 5.22, respectively. CB had L*, a* and b* values of, 53.68, 57.86, and 13.88, 
respectively. Conversely, the SB after extraction L*, a* and b* values were, 58.39, 20.09 and 
45.76, respectively, and after extraction, the CB L*, a* and b* values were, 48.47, 5.34, and 
14.2, respectively. There was a decrease in redness of CB. This may be attributed to the removal 
of astaxanthin from solid material. Chroma is a measurement of the vividness of color (higher 
values indicate a more vivid color). The chroma values for FO, FOCAX, FOSAX, and 25UAE 
were, 77.35, 73.71, 73.62, and 76.49, respectively (Table 2.3). Hue angle is defined as a color 
wheel with red-purple at an angle 0º and yellow at 90º (Ergüneş & Tarhan, 2006) The hue angle 
values for FO, FOCAX, FOSAX, and 25UAE were, 88.61, 81.15, 83.1, and 58.68, respectively 
(Table 2.3). Of the UAE samples, 25UAE had higher chroma value than 50UAE and 10UAE, 
indicating that 25UAE had a more vivid color than 50UAE and 10UAE.  
 71 
The greater the color difference amongst the oil samples correlated with the greater 
astaxanthin yield. FOCAX and FOSAX (conventional extraction) and, FO. The FOCAXUAE 
oils were referenced to FO within treatments for determining the color differences.  
 
 72 
Table 2.4 – Color in terms of L*, a*, b*, Chroma, Hue, and color difference of FOSAX, FOCAX, HFO and FO. 
Sample L* a* b* C* h* Color difference (Δ"#$∗ ) 
FO 49.03±0.15A 1.88±0.2 C 77.34±0.36 A 77.35±0.94A 88.61±1.94A NA 
HFO 52.32±0.25B 1.40±1.16 B 62.82±0.67 B 62.84±0.49A 88.72±0.75A 2.51±0.14 A 
FOAX 29.78±0.94 E 47.07±0.94D 60.00±0.94 B 76.26±0.12C 51.89±0.94A NA 
FOSAX 48.57±0.15A 8.85±0.15A 73.08±0.94 A 73.62±0.85A 83.1±0.79A 8.18±0.05A 
FOCAX 45.74±0.15 A 11.34±0.56A 64.68±0.19B 73.71±0.65A 81.15±2.01A 10.98±0.09A 
50UAE 41.87±0.94 A 30.89±1.39D 53.98±0.07B 62.19±0.92B 60.22±1.63B 37.92±0.71B, 
25UAE 39.39±0.13D 39.76±1.43D 65.35±1.32B 76.49±1.53A 58.68±1.15B 40.88±0.36B 
10UAE 31.17±0.1.47D 33.61±1.43D 60.07±1.76B 68.83±1.25B  60.77±1.31B 40.29±0.23B 
SB 60.71±0.22 C 0.15±0.02B 5.22±0.99C 5.22±0.67C 88.35±3.19A NA 
SBA 58.39±1.59C 20.09±1.23C. 45.76±1.03C 49.98±0.87D 66.30±0.67A 45.24±0.82B 
CB 53.68±1.43B 57.86±2.67E 13.88±0.99D 59.5±1.75C 13.49±0.91C NA 
CBA 48.47±1.55B 5.34±0.81 14.2±1.63D 15.17±0.83E 69.39±0.14B 52.79±0.04B 
Values are means of three determinations. A-E Means within same column bearing different letters are significantly different 
(p<0.05). FOSAX = Flaxseed oil containing astaxanthin heated at 65º C for 1 h; FOCAX = Flaxseed oil containing 
astaxanthin heated at 65º C for 1 h; FOCAXUAE = Flaxseed oil containing crawfish astaxanthin from ultrasound assisted 
extraction heated at 65º C for 1 h; HFO = Flaxseed oil heated at 65º C for 1 h; FO = Flaxseed oil; SB = shrimp processing 
byproducts (wet) before extraction; CB = crawfish processing byproducts (wet) before extraction; SBA = shrimp 
processing byproducts (wet) after extraction; CBA = crawfish processing byproducts (wet) after extraction; 50UAE = 50 
g CB with 50 g FO, 25UAE = 25 g CB with 25 g FO, 10UAE = 10 g CB with 10 g FO L* = lightness ; a* = redness; b* = 
yellowness; C* = chroma or vividness; h* = hue angle. 
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The changes in the lightness (L*), redness (a* value) and yellowness (b* value) for the 
extraction methods considered are shown in Figures 2.12, 2.13, and 2.14. Lightness does not 
seem to be affected by extraction conditions; slightly different L* values were recorded for the 
oils utilized for UAE and the oils utilized for conventional extraction. The most significant 
differences are observed in a* values, which are related to the tonality of color, possibly an 
increase in AX content of the oil, release of AX from the carotenoprotein matrix, or removal of 
AX from the shell matrix. 25UAE had higher redness (a* = 39.76) after extraction than did CFO 
(a* = 0.26). CFO (control, flaxseed oil only with ultrasound assisted extraction using 25 grams 
of crawfish processing byproducts) was lighter and less yellow (L* = 48.45 and b* = 37.15) in 
color than 50UAE, 25UAE, and 10UAE (L* = 43.31, 39.38, and 43.31 and b* = 53.98, 65.35, 
60.07, respectively). The study demonstrated that the closed ultrasound assisted extraction 
system combining ethanol with flaxseed oil could be an effective method to efficiently improve 
the extraction of astaxanthin using only 25 g of flaxseed oil and 25 g crawfish processing 
byproducts, thus increasing yield.  
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Figure 2.14. L* value, measurement of lightness to darkness in terms of CIELAB color 
scale. L* means ± SD values of triplicate determinations. A-C Means ± SD not containing a 
letter in common are significantly different (p=0.05). UTO = flaxseed oil only pumped 
through system without CB and no UAE; NFO = ethanol only pumped through system 
with CB and no UAE; 10UAE = 10 g flaxseed oil containing AX post UAE of 10 g CB; 
25UAE = 25 g flaxseed oil containing AX post UAE of 25 g CB; 50UAE = 50 g flaxseed 
oil containing AX post UAE of 50 g CB; 10 CB = 10 g crawfish processing byproducts 
(wet) after extraction; 25 CB = 25 g crawfish processing byproducts (wet) after extraction; 
50 CB = 50 g crawfish processing byproducts (wet) after extraction. 
 
Figure 2.15. a* value, measurement of red to green in terms of CIELAB color scale. A* 
means ± SD values of triplicate determinations. A-E Means ± SD not containing a letter in 
common are significantly different (p=0.05). UTO = flaxseed oil only pumped through 
system without CB and no UAE; NFO = ethanol only pumped through system with CB 
and no UAE; CFO = flaxseed oil without ethanol for UAE; 10UAE = 10 g flaxseed oil 
containing AX post UAE of 10 g CB; 25UAE = 25 g flaxseed oil containing AX post UAE 
of 25 g CB; 50UAE = 50 g flaxseed oil containing AX post UAE of 50 g CB; 10 CB = 10 
g crawfish processing byproducts (wet) after extraction; 25 CB = 25 g crawfish processing 
byproducts (wet) after extraction; 50 CB = 50 g crawfish processing byproducts (wet) after 
extraction. 
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Figure 2.16. b* value, measurement of yellow to blue in terms of CIELAB color scale. B* 
means ± SD values of triplicate determinations. A-E Means ± SD not containing a letter in 
common are significantly different (p=0.05). UTO = flaxseed oil only pumped through 
system without CB and no UAE; NFO = ethanol only pumped through system with CB 
and no UAE; CFO = flaxseed oil without ethanol for UAE; 10UAE = 10 g flaxseed oil 
containing AX post UAE of 10 g CB; 25UAE = 25 g flaxseed oil containing AX post UAE 
of 25 g CB; 50UAE = 50 g flaxseed oil containing AX post UAE of 50 g CB; 10 CB = 10 
g crawfish processing byproducts (wet) after extraction; 25 CB = 25 g crawfish processing 
byproducts (wet) after extraction; 50 CB = 50 g crawfish processing byproducts (wet) after 
extraction. 
2.3.4. Oxidative stability and quality of FO, FOSAX, FOCAX, and FOCAXUAE. 
The quality of the oil samples was evaluated by color, water content, content of free fatty 
acids (FFA), peroxide value (POV), thiobarbituric acid reactive substances (TBARS), and 
antioxidant capacities of FO, FOSAX, FOCAX, and FOCAXUAE. Following the extraction 
procedures, samples of the oils were taken for assessment of oxidative stability as a quality 
parameter. The peroxide value measures the degree of oxidation in fats and oils and measures the 
amount of total peroxides as a product of primary oil oxidation (Farhoosh & Moosavi, 2009). 
POV is a representation of the quantity of active oxygen (in mg) within 1 g of lipid that could 
oxidize potassium iodide releasing iodine. In the conventional extraction of AX from SB and 
CB, the POV of FO, FOCAX, and FOSAX were 1.27, 1.64 and 1.84 mmol O2. Kg-1, 
respectively. The POV of 50UAE, 25UAE, and 10UAE were 1.75, 1.59, and 1.35 mmol O2 . kg-1 
of oil. These values were lower than that of CFO, 4.27 mmol O2 .kg oil-1. The POV of FO 
(UTO), 0.64 mmol O2 .kg oil-1, was similar to that reported by Symoniuk, Ratusz, and Krygier 
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(2016), who measured POV ranging from 0.78 – 1.11 mmol O2 .kg oil-1. Initial results for FO, 
FOCAX, FOSAX, and FOCAXUAE showed that the oils used for extraction developed a small 
amount of peroxides. Although oils containing AX underwent oxidation during both 
conventional and novel extraction methods, extraction using the latter method resulted in a lower 
POV value. Additionally, peroxide values are used as a measurement of rancidity of oils which 
occur by auto oxidation. Furthermore, since the carotenoid portion may also be degraded during 
lipid peroxidation processes, the measurement of POV in the oils containing carotenoids may 
also provide information about color stability (Hornero-Méndez, Pérez-Gálvez, & Mínguez-
Mosquera, 2001). Greater exposure to oxygen in conventional extraction processes yielded more 
than the minimal oxidation created by the low exposure to oxygen in the novel extraction 
method. Thus, the oil obtained by UAE showed greater stability compared to the oil extracted via 
the conventional method. TBARS of 50UAE, 25UAE, and 10UAE were 1.95, 1.77, and 1.55 mg 
MDA .kg oil-1, respectively were lower than CFO, 2.11 mg MDA .kg oil-1 (see Table 2.3). After 
extraction of AX with previously mentioned methods, UAE using 25 g of CB and 25 g flaxseed 
oil (25UAE) was determined to be the best quantities for the apparatus to effectively extract 
astaxanthin efficiently and with minimal oxidative impact. Even though the lowest lipid 
oxidation, POV and TBARS, were observed with 10UAE, it was not selected for future work due 
to its astaxanthin yield being lower than that of 25UAE. Lower POV and TBARS values were 
also seen with 25UAE than with FO and conventionally extracted FOSAX. 
In addition to UAE reducing the potential degradative effects of using an increased 
temperature for extracting AX, it also had a greater yield of AX from CB. This may also be 
attributed, in part, to the freeze-drying step of the process, resulting in subsequent breakage of 
astaxanthin-protein linkages as mentioned by H.-M. Chen (1981). Additionally, the UAE 
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processing treatment of CB with ultrasound energy using the processing chamber facilitated AX 
release from the shell more than with using the conventional extraction method, similarly to the 
process of releasing biologically active compounds from bacterial cells used by (Mohideen et al., 
2015). 
During the accelerated oxidation of the oil samples at 65 °C, the POV increased linearly 
with heating the samples containing AX (see Figure 2.17). The linear regression coefficients 
were above 0.92 for the heated samples, and 0.7159 for FO at room temperature. Furthermore, a 
slower increase in oxidation is seen by the slopes of POV time curves for samples containing AX 
being below that of HFO (slope = 0.4086). The slopes of the POV time curves were 0.1508 for 
FOCAXUAE at 65 °C, 0.1851 for FOCAX at 65 °C, and 0.2401 for FOCAX at 65 °C are all 
lower than HFO. Of the heated oils containing AX, FOCAXUAE and FOCAX had the lowest 
POV after 1, 2, 3, and 4 hours of storage at 65 ºC. The function of astaxanthin as an antioxidant 
is protecting the FA within the flaxseed oil by scavenging the ROS and by stalling the 
propagation phase.   
The POV and FFA analysis of an oil are an indication of how good or bad the oil is at the 
present time. FFAs are also responsible for the acidity of oil. Increases in FFA content are 
mainly correlated to hydrolytic reactions in the oil that release glycerol and fatty acids. These 
reactions can be attributed to the moisture present in the oil. Compared to a study extracting 
astaxanthin from krill by Ali-Nehari et al. (2012), the oil used in the extraction methods here at 
relatively lower (25 ºC for UAE) and higher (60 ºC for conventional extraction) temperatures in 
this study had lower FFA content, thus having a lower aw and moisture content, as opposed to oil 
exposed to slightly higher temperatures (35 ºC, 40 ºC, and 45 ºC).  
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Figure 2.17. Peroxide values FO, HFO, FOCAX, FOSAX, and FOCAXUAE. FOCAX = 
Flaxseed oil containing crawfish astaxanthin heated at 65º C for 0-4 h; FOSAX = Flaxseed oil 
containing shrimp astaxanthin heated at 65º C for 0-4 h; FOCAXUAE = Flaxseed oil containing 
crawfish astaxanthin from ultrasound assisted extraction heated at 65º C for 0-4 h; HFO = 
Flaxseed oil heated at 65º C for 0-4 h; FO = Flaxseed oil not heated for 0-4 h. 
Table 2.5 Slope, y intercept, and correlation coefficients for linear regression of POV of Oils not 
heated and heated at 65 ºC vs. time. 
Oil sample Slope y Intercept Linear regression coefficient 
FO 0.165 0.2267 0.7159 
HFO 0.4086 1.7832 0.9615 
FOSAX 0.2401 1.832 0.9986 
FOCAX 0.1851 1.7177 0.9952 
FOCAXUAE 0.1508 1.6335 0.9257 
FOSAX = Flaxseed oil containing astaxanthin heated at 65º C; FOCAX = Flaxseed oil 
containing astaxanthin heated at 65º C; FOCAXUAE = Flaxseed oil containing crawfish 
astaxanthin from ultrasound assisted extraction heated at 65º C; HFO = Flaxseed oil heated at 65º 
C; FO = Flaxseed oil at room temperature. 
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Figure 2.18. Thiobarbituric acid reactive substances of HFO, FOCAX, FOSAX, and 
FOCAXUAE samples at 65 ºC. FOCAX = Flaxseed oil containing crawfish astaxanthin heated at 
65º C for 0-4 h; FOSAX = Flaxseed oil containing shrimp astaxanthin heated at 65º C for 0-4 h; 
FOCAXUAE = 25 g Flaxseed oil containing crawfish astaxanthin from ultrasound assisted 
extraction heated at 65º C for 0-4 h; HFO = Flaxseed oil heated at 65º C for 0-4 h. 
2.3.5 DPPH (2,2 diphenyl-1-picryl-hydrazyl-hydrate) radical scavenging activity 
Antioxidant activity of AX extracts were determined by DPPH radical-scavenging assay 
(Roy et al., 2010). DPPH, a stable free radical at room temperature, has been used to evaluate the 
effectiveness of various antioxidant substances at free radical scavenging. The ability of 
astaxanthin extracts to inhibit the DPPH reaction was expressed in DPPH• inhibition (%) as 
shown in Figure 2.18.  The decolorization of DPPH solution from purple to a yellow-colored 
compound (Reaction 2.1.), which is dependent upon the extent of hydrogen-donating ability 
during the reaction, is related to the decrease in the absorbance at 517 nm (Nagarajan, Rani, 
Narayanasamy, & Masthan, 2019). 
DPPH• + AH®DPPH-H + A•       (Reaction 2.1.) 
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The higher the DPPH scavenging (% inhibition), the higher the antioxidant activity of the 
sample. The FOCAXUAE sample had the greatest DPPH• scavenging ability, of all the samples 
and concentrations used and exhibited a higher DPPH scavenging activity than that of the control 
throughout the assay. At the end of the period, all the samples, except for the control (FO) 
showed scavenging activity greater than 50%. The results are in agreement with data reported by 
Taksima, Limpawattana, and Klaypradit (2015), supporting that AX functions as an antioxidant 
in donating H to terminate the chain reaction in lipid oxidation. Other researches have also 
reported that astaxanthin has a primary antioxidant function by donating electrons to unpaired 
electrons to neutralize free radicals or abstracting an unpaired electron which also can neutralize 
a radical (Kidd, 2011). The propagation step of lipid peroxidation is inhibited by the interaction 
of AX with free radicals and with oxygen.  
The scavenging effect of AX extracts and standard FO on the DPPH• decreased in the 
order of FOCAXUAE (1.9 mg.g-1 oil), FOCAX (0.92 mg.g-1 oil), FOSAX (0.54 mg.g-1 oil), FO 
(0.0 mg.g-1 oil) equivalent to ascorbic acid (20 mg.100 ml-1 ethanol), 85.85, 82.97, 82.82, and 
70.85%, respectively. 
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Figure 2.19 Antioxidant activity of different astaxanthin extracts in flaxseed oil determined by 
DPPH scavenging activity. FOCAX = flaxseed oil containing astaxanthin (0.92 mg/g) 
conventionally extracted from crawfish processing byproducts (n = 3). FOSAX = flaxseed oil 
containing astaxanthin (0.54 mg/g) conventionally extracted from shrimp processing byproducts 
(n = 3). FOCAXUAE = 25 g flaxseed oil containing astaxanthin (1.9 mg/g) from ultrasound 
assisted extraction of crawfish processing byproducts (n = 3). FO = flaxseed oil. Error bars 
indicate standard deviations. 
. 
For the reduction of DPPH, the standard curve was linear between 0–20 mg of ascorbic 
acid/100 mL. The absorbance response (y) of vitamin C (y = − 0.039x + 0.0683, r2 = 0.9785) 
concentrations was linear, having a strong coefficient of determination. The activity of three 
different extracts and the control was determined, with all tests performed in triplicate. The 
greatest DPPH• inhibition % after 30 minutes was with FOCAXUAE, 80.18±1.02, with FOCAX 
and FOSAX behind, 58.44±0.22 and 50.71±0.33, respectively. The differences in antioxidative 
activity between extracts were mostly due to the slightly differing concentrations of AX present. 
Additionally, the potential isomerization of the astaxanthin molecule contributes to the increased 
DPPH• scavenging activity. S. Yang et al. (2015) reported that in 9-cis-astaxanthin has a greater 
antioxidant activity than 13-cis-astaxanthin, and the predominant naturally found, all-trans-
astaxanthin. According to S. Yang et al. (2015), thermal processing has been found to induce the 
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formation of 9-cis-astaxanthin. Recall, that the crawfish processing byproducts had been 
thermally processed (parboiled) before the analyses. 
2.4 Conclusion 
Preliminary investigations of total extractable AX using solvents revealed that crawfish 
processing byproducts consisted of more astaxanthin than shrimp processing byproducts. 
Therefore, future investigations will focus on crawfish processing byproducts. Flaxseed oil 
containing astaxanthin (FOAX) derived from crawfish processing byproducts (CB) or shrimp 
processing byproducts (SB) were produced by extraction with two different techniques. The 
conventional method used to produce FOAX required more time and used a larger quantity of a 
valuable solvent, flaxseed oil (FO). A novel method was designed, developed and tested that 
produced greater yields of astaxanthin than conventional methods. The novel method employs 
the use of ultrasonication and ethanol combined with FO in a continuous system. The different 
extraction methods and types of processing byproducts showed significant differences in the 
amount of AX extracted. Even pre-treatment improved the recovery of extractable astaxanthin. 
Previous studies suggest similar end results (H.-M. Chen & S. P. Meyers, 1982). The FOAX 
created in all extraction methods had a specific gravity similar to the control FO. Color data 
revealed a significant relationship between a* and AC. Color data did not reveal any other 
significant information as it pertained to any quality parameters evaluated. FOAX from CB by 
ultrasound assisted extraction (UAE) had a significantly lower moisture content than the other 
FOAX extracts. The FOCAXUAE exhibited a greater oxidative stability than other FOAX 
extracts, FOCAX or FOSAX, by conventional extraction. Additionally, astaxanthin recovery 
using the combined ethanol and flaxseed oil UAE method was more efficient than conventional 
extraction method, recovering more than twice the amount of astaxanthin. Compared to other 
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extraction methods considered, the utilization of ultrasound sonication combined with ethanol 
and flaxseed oil in a closed system proved to be capable of improving the extraction efficiency of 
astaxanthin (w/w).  and minimizing the lipid oxidation significantly compared to CFO. 
Additionally, the antioxidant capacity was greatest with the utilization of freeze-dried parboiled 
CB for UAE.  
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CHAPTER 3  DEVELOPING ENTRAPPED FLAXSEED OIL 
CONTAINING CRAWFISH ASTAXANTHIN IN A PECTIN-GELATIN 
MATRIX GUMMY 
 
3.1 Introduction 
The increasing public perception of the correlation between diet and human health, has 
caused food manufacturers to developed various foods with health-promoting/protective 
compounds. Many of those compounds are dietary carotenoids (antioxidants), nutrients that 
impart protective effects on human health. Astaxanthin (AX) is a natural pigment that imparts 
red color to microalgae, salmon, trout, shrimp, crawfish, and flamingos. Moreover, AX has been 
shown to reduce the risk of developing cardiovascular disease, age-related macular degeneration, 
and breast cancer (Fassett & Coombes, 2012; Grimmig, Kim, Nash, Bickford, & Shytle, 2017; 
Inoue et al., 2017; Satoh, 2016).  
The efficiency of carotenoids absorption (bioaccessibility) may limit their biological 
actions. Carotenoids are highly lipophilic molecules and must be incorporated within delivery 
systems to overcome physiological or physicochemical challenges that limit their efficacy, such 
as an unsuitable matrix, which directly impacts oral bioavailability, and chemical, or biochemical 
instability; and poor water solubility (McClements & Li, 2010). Emulsion-based delivery 
systems are one of the most suitable candidates for entrapping and delivering lipophilic 
biologically active compounds and they are relatively simple and economical to produce (Z. 
Zhang, Zhang, Chen, Tong, & McClements, 2015). Examples of such delivery systems include 
nanofibers, filled hydrogel particles, and colloidal suspensions such as emulsions, 
microemulsions, nanoemulsions, and multiple emulsions. 
The consumption of dietary carotenoids is reported to have an inverse relationship with 
the risk of major clinical diseases, such as cancer. Dietary carotenoids have health benefits that 
 85 
are associated with their bioavailability and metabolic fate. However, due to the lipophilic nature 
of astaxanthin and poor solubility in water, it has a low bioavailability. Therefore, a vehicle for 
effective delivery of astaxanthin is needed. Delivery of bioactive compounds to a right place at a 
right time or controlled release of a compound is one of the important roles of encapsulation. 
Encapsulation for controlled release could improve the bioaccessibility of biologically active 
compounds, increase the application range of food ingredients and ensure effective dosing (Desai 
& Park, 2005; Lu, 2017; Trojer, Nordstierna, Nordin, Nydén, & Holmberg, 2013). A specific 
barrier formed by encapsulation manipulates release of active compounds to provide functional 
benefits and unique sensory properties (Lakkis, 2007).  
Hydrogels formed by cross-linkages between hydrophilic polymeric chains may be 
natural or synthetic (Matalanis, Decker, & McClements, 2012; Neves et al., 2015). The structural 
integrity of a hydrogel depends on the crosslinks formed between polymeric chains, via different 
types of physical interactions of chemical bonds (Neves et al., 2015). Typically, a filled hydrogel 
contains oil droplets trapped within the biopolymer network (Z. Zhang et al., 2015). Gelatin may 
have a very glossy surface due to the amount of regular reflection from the surface being high 
and the amount of diffuse low. Conversely, gummies containing HPMC have visually matte 
surfaces with greater amount of diffuse reflection, suggesting a more irregular surface.   
Astaxanthin has gained much medical attention due to its health protective benefits. 
Astaxanthin, is a naturally occurring antioxidant that can neutralize unstable free radicals that are 
linked with the development of a number of diseases such as cancer, cardiovascular disease and 
age conditions such as Alzheimer’s and macular degeneration. The biological activity of 
astaxanthin is highly dependent on intestinal absorption, and is why the food matrix or other 
delivery system is important. Several delivery systems have been developed as carriers for 
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astaxanthin to protect its biological activity from environmental factors and enhance its stability. 
Such delivery systems include nanodispersions, microencapsulations, and lipid carriers(Hama et 
al., 2012; I Higuera-Ciapara, Felix-Valenzuela, Goycoolea, & Argüelles-Monal, 2004; Xiaojuan 
Liu et al., 2018; Shen, Zhao, Lu, & Guo, 2018; Tamjidi, Shahedi, Varshosaz, & Nasirpour, 2014, 
2018). Previous work has also investigated the encapsulation of a lipid extract containing 
astaxanthin by complex coacervation using gelatin and cashew gum (Gomez-Estaca, Comunian, 
Montero, Ferro-Furtado, & Fávaro-Trindade, 2016).   
In the present work, the efficiency of lm-pectin-gelatin and hm-pectin-gelatin 
coacervation systems with and with hydroxypropyl methylcellulose (HPMC) to encapsulate core 
material (FOCAXUAE) were compared. Qi et al. (2013) reported a key interaction between bile 
salts in the gut environment and HPMC that resulted in dissolution and subsequent absorption of 
water-soluble drugs. The inclusion of HPMC into the delivery system contributed to 
micellarization and intestinal absorption of astaxanthin.  The loading efficiency and release 
characteristics of the two coacervation systems (with and without HPMC) were considered.  
3.2 Materials and Methods 
Gelatin solutions were prepared by hydrating type A gelatin (Knox Original Gelatine, 
Unflavored, Kraft Foods, Northfield, IL), purchased from a local grocery store, in distilled water. 
Pectin solutions were prepared separately with high-methoxyl pectin (Pre-Hydrated® HM Rapid 
Powder, HMP, Lot # 43621, DE>50%, 181 kDa mw) and low-methoxyl pectin (TIC Pretested® 
Pectin LM 32 Powder, LMP, Lot # 571091, 32% DE, 130 kDa mw), both kindly provided by 
TIC Gums (Belcamp, MD), to distilled water with agitation overnight to ensure complete 
hydration. Sunflower lecithin powder (lecithin, see Table 3.1 for lipid content) was purchased 
from Now Foods (Bloomingdale, IL). Hydroxypropyl methylcellulose (HPMC, MW ∼10 kDa, 
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methoxyl content ~28 wt. %, hydroxypropoxy content ~9.5 wt. %, equivalent to Methocel E, 
viscosity grade 60 cP, Alfa Aesar, Germany), and was purchased from Fisher Scientific. Ethanol 
(190 proof), chloroform, and methanol were all analytical grade solvents. 
  Sunflower lecithin (5% wt. of FOCAXUAE wt.) was used as emulsifier to prepare the oil 
phase containing sodium deoxycholate (1% wt. of FOCAXUAE). This oil phase was manually 
distributed into the aqueous phase to an oil fraction of 32 g/ 26 g of pectin solution (10% wt.). 
The coarse O/W emulsions obtained were sonicated using an ultrasound processor (Cole Palmer) 
in a dry ice, ethanol slurry under a nitrogen flux to prevent thermally induced lipid oxidation.  
High-methoxyl apple pectin (HMP) and low-methoxyl pectin (LMP) were kindly 
provided by TIC Gums (Belcamp, MD). Glucose syrup (Karo Light corn syrup, ACH Food 
Companies, Inc., Oakbrook Terrace, IL, USA) was purchased from Walmart. 
Table 3.1. Phospholipid content in sunflower-lecithin. 
Naturally occurring phospholipids (per serving) (10 g): 
Phosphatidyl Choline 2.5 g  
Phosphatidyl Inositol 1.8 g 
Phosphatidyl Ethanolamine 1.1 g 
 
3.2.1 Preparation of FOCAXUAE for gummy fabrication 
A stock FOCAXUAE was prepared by concentrating (5) subsequent FOCAXUAE 
extractions with the same FO and E ratio as previously described in section 2.2.3.2. of Chapter 2, 
with slight modification. To effectively concentrate astaxanthin, crawfish processing byproducts 
(CB) were replaced with a new batch of CB after each 10-minute ultrasound assisted extraction 
cycle. Following the extraction period, the CB were washed with ethanol until clear. Then the 
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filtrate was pooled and complete evaporation of the ethanol was accomplished by using a rotary 
evaporator (Büchi Rotavapor R-114, Büchi Labortechnik AG, Flawil, Switzerland). This 
produced a concentrated FOCAXUAE (35 ml). 
3.2.2 Preparation of Emulsions 
Oil in water emulsions with desired concentrations of low- or high-methoxyl pectin 
containing concentrated FOCAXUAE were prepared by a method of Couëdelo et al. (2010) at 
room temperature with slight modification. The aqueous phase, emulsifier solution was prepared 
by first dissolving HMP or LMP in distilled water overnight to allow complete hydration, 
followed by the subsequent addition of lecithin (20% wt. of oil). The amount of FOCAXUAE in 
the O/W emulsion was adjusted so that each gummy contained approximately 10% FOCAXUAE 
of the total weight of the gummy after setting. Emulsions prepared with HPMC, were prepared 
without lecithin.  
3.2.2.1 Emulsion Stability 
The stability of the emulsions was assessed according to a method described by 
Mohideen (2011) with modifications. Emulsion samples (3 g each) were placed in 13 x 100 mm 
disposable borosilicate glass culture tubes (Kimble, Vineland, NJ) in a tube rack on a benchtop at 
room temperature (25±0.5 °C) for 2 days. Next the samples were centrifuged at 1163 x g for 30 
minutes (BD-Clay Adams Compact II centrifuge), and the amount of emulsion cream separated 
was measured. To determine the emulsion stability, or inability of phases to separate, the percent 
of oil to separate from the emulsion must be calculated. The oil recovery percentage was 
calculated using equation 3.1. The emulsion stability (ES) was determined using equation 3.2.  "#$	&'()*'&+	("-)	%	 = 	 123456	78	739	:2;7<2:2=	>?@9A37B	123456	(3B363C9) × 100                        (Eq. 3.1)  
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where oil separated is the weight of the oil separated from the cream layer after centrifugation 
treatment.  GHI$J#)K	LMNO#$#M+	(GL) = 	100	% − "-%                         (Eq. 3.2) 
3.2.3 Formulation and production of pectin-gelatin delivery system  
Pectin-gelatin delivery system (PGDS) were prepared using the method of DeMars and 
Ziegler (2001) with modifications. Table 3.2 shows the PGDS recipes. Figure 3.2 is a flow 
diagram for the preparation of the gummies. Each batch was made using the same amounts for 
sugar slurries (brought to 240 g by addition of distilled water). O/W emulsions were prepared 
such that when added to gelling slurries (gelatin, ~15-30 g) and the desired amount of gelatin and 
pectin were achieved. Gelling slurries were formulated such that the final PGDS contained the 
desired concentration of pectin and gelatin to facilitate associative interactions without 
precipitation of either. Additionally, for a confectionery gummy production, it is essential to 
include glucose syrup in proportional amounts to sugar (1:1) to prevent crystallization of the 
sugar. In the present work, the word “gummy” and “PGDS” are used interchangeably.   
After both solutions (gelling slurry and sugar slurry) were mixed under constant stirring 
for 10 minutes, the homogenous viscous solutions obtained were poured into 160 square cavity 
silicone molds. Each resulting gummy cube had a volume of 1 cm3 (quantity of solutions 
deposited in the mold were estimated to be the same for all gummies when pouring). Once the 
trays filled, they were placed in the refrigerator for 48 hours to achieve gel consistency. Each 
gummy candy weighed 1±0.03 g. After gelling they were removed from the molds and lightly 
dusted with powdered sugar to prevent them from sticking. They were then placed in square 5.5 
in. x 5.5 in. weigh dishes to dry at room temperature (25±0.5 ºC) for another 48 h. For release 
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PGDS cubes were placed in separate conical tubes (50 ml) and refrigerated. PGDS with FO in 
the emulsion preparation step was prepared as a blank. 
Table 3.2. Design and development of pectin-gelatin gummy pieces.  
Ingredients (g) PGDS1 (pH 3.55) 
PGDS2 
(pH 2.85) 
PGDS3 
(pH 2.8) 
PGDS4 
(pH 2.8) 
PGDS5 
(pH 2.9) 
PGDS6 
(pH 2.9) 
PGDS7 
(pH 2.9) 
Sucrose** 101 111 101 111 111 102 102 
Corn syrup** 91 103 91 103 103 90 90 
H2O** 100 100 100 120 120 50 50 
LMP*  2  4  3  
HMP* 4  2  4  3 
HPMC*      5% w/w 5% w/w 
dH2O*      60 60 
Gelatin*** 15 30 30 30 30 15 15 
H2O***  30 30 30 30 30 20 20 
FOCAXUAE* 30 20 20 30 32 32 32 
Tween 20  0.27 0.4 0.35 0.4 0.27 0.27 
Ascorbic acid 2 2.5 2.7 11.46 3 6 7 
Note: PGDS1- PGDS7 are prepared with pectin (LMP or HMP), with or without HPMC, 
FOCAXUAE, and distilled (d) H2O*. Sucrose (table sugar), corn syrup (Karo®, ACH Food 
Companies, Inc., Oakbrook Terrace, Il.)), and dH2O**. Type-A gelatin hydrated with dH2O*** 
becomes the gelling solution*** Tween 20 was added during the mixing of the three final 
solutions followed by lowering the pH with 50% food grade citric acid solution. HPMC is 5% of 
final emulsion (g). The ingredient ratios of PGDS1 were not capable of forming the desired 
delivery system, thus no further work was done on PGDS1. 2• 
 
2* denotes the emulsion containing pectin, dH2O, and FOCAXUAE. ** denotes the sugar slurry, *** denotes the 
gelling slurry. 
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Figure 3.1. Flow diagram for preparation of FOCAXUAE pectin gelatin delivery system. To 
promote coacervation, the pH was changed to ~3 ± .5 with citric acid (50% v/v food grade citric 
acid and distilled water) at 25 ± 0.5 °C under a stirring rate of 600 rpm for 30 min to achieve 
uniform mixing, complete complex coacervation, and minimize aeration. Source: Muhoza, Xia, 
and Zhang (2019).  
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3.2.4 Water Activity and soluble solids content of pectin gelatin cubes 
After PGDS fabrication, their water activity (aw) were evaluated. The aw of samples was 
determined using a Pawkit aw meter (AquaLab Pawkit, Decagon Devices Inc., Pullman, WA) at 
25 ± 0.5 °C. To determine total soluble solids (TSS) of the PGDS, distilled water (DW) was 
combined with macerated PGDS (1:1 g/g).  TSS was then determined from the mixture by 
refractometry, using a digital refractometer (AR200, Reichert Analytical Instruments, Depew, 
NY, USA) with values expressed in Brix (°Brix). All analyses were carried out in triplicate. 
3.2.5 Determination of FOCAXUAE content in PGDS 
Using a modified method of Blighs and Dyer (1959) for extracting total lipids, the 
astaxanthin content in the PGDS was determined. To quantify the mass (g) of total lipid initially 
loaded in a PGDS, a 50 mL tube containing macerated PGDS (5 g ± 0.1) and 2.5 mL DW was 
added. Then a ternary solvent system was created as follows: for each gram of sample, 3.75 mL 
of 1:2 CHCL3: MeOH was added and vortexed (1000 rpm) until complete dissolution had 
occurred or for 90 seconds. Then an additional two mL of DW was mixed with the sample and 
vortexed a second time (30 seconds). The alcoholic layer containing non-lipids (top layer) was 
carefully removed by aspiration using a syringe and the CHCL3 fraction (bottom layer) 
containing the lipids was added to a tared vial. The solvent was evaporated from the tared vial 
using an analytical evaporator until constant weight was achieved. The cooled vial was weighed, 
and the weight of the lipid residue recorded. Triplicate determinations were performed for each 
sample. The average values were recorded as, Total FOCAXUAE content (TFC) in PGDS.  
3.2.6 Determination of lipid released and astaxanthin content in PGDS  
The amount of lipid released was determined in the same manner as TFC, except that the 
released material from the gummies was used instead of macerated gummies. The amount of 
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astaxanthin in the gummy was proportional to amount of oil quantified per gummy. Three PGDS 
samples were weighed (data recorded as initial PGDS weight) and placed inside 50 mL conical 
tubes for dissolution studies.re placed on a tared balance and the weights recorded. For 
quantification of lipid released, 11.25 mL of 1:2 CHCL3: MeOH were added to each 50 mL 
conical tube containing PGDS samples and 10mL of dissolution media and vortexed (1000 rpm) 
for 60 seconds. The alcoholic layer containing non-lipids (top layer) was carefully removed by 
aspiration using a syringe and the CHCL3 fraction (bottom layer) containing the lipids was added 
to a tared vial. The solvent was evaporated from the tared vial using an analytical evaporator 
until constant weight was achieved. The cooled vial was weighed, and the weight of the lipid 
residue recorded. Triplicate determinations were performed at each designated time. The 
averaged values were recorded as lipid released. 
Astaxanthin content of total lipid extracted from the gummy was measured using to the 
method of Saito and Regier (1971) with a slight modification. Following “Determination of 
FOCAXUAE content in PGDS” (see section 3.2.5.) and the determination of lipid released in 
PGDS in this section, 30 mg of recovered oil was mixed with 10 ml of petroleum ether (PE) and 
allowed to stand for 30 min. The absorbance of oil, appropriately diluted, was measured at 468 
nm using a GENESYS 20 UV-Vis spectrophotometer (Thermo Fisher Scientific, Inc., Rochester, 
NY, USA). The concentration (C) of astaxanthin in the PGDS was calculated using the equation 
given by Saito and Regier (1971) with a slight modification as follows: QRS	(TU U⁄ lipid) = [\]^	×	<79@?2	78	_>		×	=39@637B	8C;67:`.b	×	123456	78	AC?c92	@A2=	3B	4:C?                     
(Eq. 3.3) where 0.2 is the A468 of 1 μg/ml standard astaxanthin and 1 is the dilution factor of the 
sample. 
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3.2.7 Swelling and Release media 
In order to examine the potential of the pectin-gelatin delivery system (PGDS) gummy as 
a delivery system for bioactive compounds, release characteristics of PGDS with entrapped 
FOCAXUAE were investigated in release media. The gastrointestinal (GI) tract environment was 
modeled with two simulated digestive fluids as described by Chotiko and Sathivel (2017) and 
Taylor et al. (2019) with some modifications. In accordance with the United States 
Pharmacopeia, simulated gastric fluid (SGF at pH 1.2, without pepsin) consisted of 2 g of 
sodium chloride (Fisher Scientific Inc., Pittsburgh, PA), 7 mL of hydrochloric acid (Fisher 
Scientific Inc., Pittsburgh, PA), and distilled water used to adjust the total volume to 1 L. For 
simulated intestinal fluid (SIF at pH 6.8, without enzyme), 6.805 g of monobasic potassium 
phosphate (Sigma Aldrich, St. Louis, MO) and 0.896 g of sodium hydroxide (Fisher Scientific 
Inc., Pittsburgh, PA) were dissolved in distilled water and the total volume was adjusted to 1 L.  
3.2.7.1 Swelling Studies 
Swelling of hydrogels affects the controlled release of the compounds entrapped in the 
hydrogel matrix (Xiudong Liu et al., 2004). To evaluate the water sorption resistance of the 
PGDS with entrapped astaxanthin, three samples were weighed (Wd), 1±0.03 g each and then 
immersed in 30 mL of dissolution media (distilled water (DW), simulated gastric fluid (SGF pH 
1.2) or simulated intestinal fluid (SIF pH 6.8) at 37 °C, with shaking (50 rpm). Swollen gels were 
removed from dissolution media at predetermined time intervals, blotted dry, and weighed (Wf) 
to track sorption kinetics. The swelling index (SI) was determined as described by (Raafat, Eid, 
& El-Arnaouty, 2012) using the equation below. Each tube was initially prepared with equal 
volumes of dissolution fluids.  Ld	(%) = 	efgehef × 	100                (Eq. 3.4) 
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Where Wf and Wi are the weights of swollen and dry gummies, respectively 
3.2.7.2 In vitro Release Study 
Release of astaxanthin from PGDS was investigated in SGF and SIF for 120 and 180 
min, respectively as described by Chotiko and Sathivel (2017) and Taylor et al. (2019) with 
some modifications. Three grams of PGDS were placed in 50 ml conical tubes containing 10 ml 
of SGF or SIF. The tubes were incubated with continuous agitation, at 50 rpm about their 
horizontal axis in a circular motion using an orbital shaker incubator equipped with a 
temperature control system (37 °C). Three individual tubes were sampled at predetermined time 
intervals to determine FOCAXUAE released during incubation. Astaxanthin content in the 
gummies was determined by the methods mentioned in sections 3.2.5 and 3.2.6 above. 
The amount of lipid released was determined by the method mentioned above in section 
3.2.6. With the amount of lipid released and the concentration of astaxanthin (mg) per g of oil, 
the bioaccessibility of AX can be determined.  (%)	i#)N(('J#O#$#M+ = 	 C?7@B6	jklmnom>	:2;7<2:2=	8:7?	_pqr	C6	2C;5	63?2	(?4)C?7@B6	78	jklmnom>	3B363C99s	97C=2=	3B	_pqr	(?4) × 100  (.3.5) 
Bioaccessibility can be defined as the theoretical amount of astaxanthin available for 
absorption. The amount of FOCAXUAE initially loaded per PGDS is ~200 mg per a ~2g gummy 
and ~100 mg per 1 g gummy, based on the method in section 3.2.5. Triplicate determinations 
were performed for each sample. 
3.2.8. Morphology using scanning electron microscopy (FIB-SEM) 
Freeze dried gummies (PGDS2, PGDS3, PGDS4, PGDS5, PGDS6, PGDS7) were 
mounted on aluminum scanning electron microscopy (SEM) specimen stubs and coated in an 
Edwards S150 sputter coater with platinum. Coated gummies were observed using a dual-beam 
scanning electron microscope (FEI Quanta 3D FEG FIB-SEM) instrument (Louisiana State 
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University, Louisiana) interfaced with EDAX EDS/EBSD system at an acceleration voltage of 
5kV and 3 pA under high vacuum. SEM micrographs were used to obtain information about the 
surface morphology and encapsulated bioactive compound. 
3.2.8 Statistical Analysis 
Mean values and standard deviations of triplicate reproducible analyses are reported. The 
statistical significance of observed differences among treatment means was evaluated by analysis 
of variance (ANOVA) was carried out to determine the difference among treatments means with 
SAS software Version 9.4 (SAS Institute Inc., Cary, NC) using a post hoc Tukey's studentized 
range test (SAS, 2013). 
3.3 Results and Discussion 
3.3.1 Water activities, moisture, soluble solids, and astaxanthin content of the delivery 
system 
 
  Protein and polysaccharide interactions play an important role in the structure and 
stability of foods and food products. A key factor in fabricating novel food products is the 
control and manipulation of macromolecular interactions between hydrocolloid constituents. The 
functional properties of proteins are affected by their interactions with polysaccharides, and vice 
versa. Analyses were performed on delivery system to determine the moisture and water activity 
of the PGDS samples. Results are shown in Table 3.3. PGDS7 and PGDS6 had the lowest water 
activity, which may be due to the hydrophilicity of HPMC, a synthetic polymer, binding more 
water. 
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Table 3.3. Compositional parameters of pectin gelatin delivery systems (PGDS) 
 Water activity Moisture (%) Soluble solids (ºBrix) AC (mg) 
PGDS2 0.81 ± 0.011 D 25.20 ± 0.10 B 75.27 ± 0.25 C 0.27 ± 0.02 B 
PGDS3 0.77 ± 0.005 B 25.03 ± 0.15 B 73.43 ± 0.02 B 0.27 ± 0.02 B 
PGDS4 0.79 ± 0.006 C 26.93 ± 0.23 B 73.24 ± 0.03 B 0.38 ± 0.04 B 
PGDS5 0.79 ± 0.006 C 27.00 ± 0.2 B 71.49 ± 0.03 A 0.43 ± 0.05 A 
PGDS6 0.76 ± 0.015 B 20.76 ± 0.06 A 71.69 ± 0.01 A 0.54 ± 0.02 A 
PGDS7 0.73 ± 0.003 A 20.95 ± 0.07 A 70.73 ± 0.02 A 0.54 ± 0.01 A 
Note: A-D Means ± SD not containing a letter in common are significantly different (p=0.05). 
Each PGDS weighs 1±0.03g. PGDS2 - 2% LMP:8% G, pH 2.85 (5%); PGDS3 - 2% 
HMP:8% G pH 2.8 (5%); PGDS4 - 4% LMP:30% G pH 2.8 (8%); PGDS5 - 4% HMP:30% 
G pH 2.9 (8%); PGDS6 - 3% LMP:15% G:5% HPMC pH 2.9 (10%); PGDS7 - 3% 
HMP:15% G:5% HPMC pH 2.9 (10%); AC = astaxanthin content 
 
Developed gels potentially affect carotenoid bioaccessibility. High-DM pectin increases 
the lipolysis, bile salt binding, and micellarization (conversion into micelles) of polar 
carotenoids, resulting in increased uptake (Cervantes-Paz et al., 2017). Conversely, low-DM 
pectin can reduce the levels of calcium involved in the lipolysis and generation of lipid digestion 
products for micelle formation, thus decreasing carotenoid uptake (Devraj et al., 2013). 
The admix of ingredients and setting times play an essential role in the formulation and gel 
strength of products. The heterogeneous structures produced by the gummy formulations can be seen 
in Figure 3.3., Figure 3.4 (glossy concave top surface), Figure 3.5 (glossy concave top surface), Figure 
3.6, and Figure 3.7 (incompatibility of gelatin and pectin, concave structures, and surface haze, 
respectively), with the exception of PGDS7 and PGDS6 (Figure 3.8. and 3.9. This is explained by the 
lack of favorable polymer interactions in forming gel networks with different concentrations of LMP 
and lack of cations or the rapid gel formation of different concentrations of HMP at a pH lower than 3 
and coalescence of FOCAXUAE droplets. It was reported that an increase in ionic strength of the 
media over 0.1 mM decreased the coacervation yield of gelatin (Burgess & Carless, 1985). The SIF 
had an ionic strength greater than 0.1 mM as a result of the 0.896 g of NaOH/liter (0.22 mM), 
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therefore further complex coacervation between gelatin and pectin was unlikely to occur. This 
supports the need for HPMC in developing a gel that is capable of withstanding the GI environment.  
    
Figure 3.2.  Addition of FOCAXUAE to   Figure 3.3. PGDS1 - 4% HMP:15% G pH  
emulsion with pectin and gelatin.   3.55 (12%). 
 
    
Figure 3.4. PGDS2 - 2% LMP:8% G,   Figure 3.5. PGDS3 - 2% HMP:8% G pH 
pH 2.85 (5%).      2.8 (5%). 
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Figure 3.6. PGDS4 - 4% LMP:30% G   Figure 3.7. PGDS5 - 4%  
pH 2.8 (8%).        HMP:30% G pH 2.9 (8%). 
                  
      
Figure 3.8. PGDS6 - 3% LMP:15% G:5%   Figure 3.9. PGDS7 - 4% LMP:15% 
HPMC pH 2.9 (10%).      G:5% HPMC pH 3.55 (10%). 
The segregative interactions among pectin and gelatin biopolymers (without a nonionic 
surfactant (HPMC)) are seen in Figure 3.3. The emulsion phase containing FOCAXUAE can be 
seen atop the translucent gelatin phase, Figure 3.3. With PGDS1, it is clear that the upper phase 
is rich in FOCAXUAE: pectin (reddish orange in color) while the lower is rich in gelatin 
(translucent). The segregation is due to the incompatibility between positively charged gelatin 
(pI∼7) and neutral FOCAXUAE: pectin. Phase separation due to the segregative interactions 
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occurs above a certain concentration of polymers at which they become thermodynamically 
favorable (Doublier, Garnier, Renard, & Sanchez, 2000).  
3.3.2 Swelling and Release Study 
According to previous research by Sriamornsak, Nunthanid, Cheewatanakornkool, and 
Manchun (2010), the release of a compound from a hydrogel matrix is divided into two phases, 
rapid release period, and a declining rate period. In some cases, the first phase would be 
governed by two mechanisms that dictate drug compounds release from a matrix, swelling and 
diffusion. The second phase, is more or less a period of steady release or erosion, rather than a 
declining rate, although that rate is lower than the rate of release due to swelling and diffusion. 
During such period, the gel swelling has reached equilibrium (Brannon-Peppas & Peppas, 1991). 
However, such phenomena are seen with water-soluble compounds integrated in a matrix, while 
for low water-soluble compounds like carotenoids, self-erosion of the matrix is the primary 
release mechanism.  
Release of FOCAXUAE from the delivery systems was investigated in SIF and SGF. 
When incorporating bioactive compounds into a product for human consumption, one factor that 
goes into the development and design is the delivery system, which encompasses the release of 
the bioactive components into a targeted region to facilitate their absorption. 
3.3.2.1 Swelling Study 
The swelling index indicates the percentage swelling of the delivery system caused by the 
uptake of the dissolution media and subsequent growth. With there being no polymer erosion, the 
water uptake and swelling resulted in an increase in weight. Greater water uptake was seen in 
PGDS7 (high-methoxyl) than with PGDS6 (low-methoxyl) in SIF, SGF, and DW dissolution 
medias, Figure 3.10 and Figure 3.11, respectively. Water uptake between PGDS7 and PGDS6 
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did not differ in DW, see Figure 3.12. Swelling initially occurred, within 15 minutes, among all 
formulations in both SGF at pH 1.2 and SIF at pH 6.8. Swelling was most profound in SIF for 
PGDS7 with a SI of 126.46±5.1% after 180 minutes followed by PGDS6 with a SI of 
90.61±6.8% after 60 minutes. This further confirms that the prepared delivery systems, PGDS6 
and PGDS7, have the capability to withstand the intestinal tract and its environments. The other 
delivery systems failed to maintain their structure and either gelled or eroded completely and had 
swelling indices under 30%. The large swelling indices of HPMC gummies (PGDS7 and 
PGDS6) can be attributed to the hydrophilicity of HPMC.
 
Figure 3.10. Swelling index studies of pectin-gelatin based delivery systems loaded with 
FOCAXUAE in simulated intestinal fluid (SIF pH 6.8). PGDS7, 3% high-methoxyl pectin 15% 
gelatin gummies coated with HPMC (5% wt.) pH 3.55; PGDS6, 3% low-methoxyl pectin 15% 
gelatin gummies coated with HPMC (5% wt.) pH 2.9; PGDS5, 4% high-methoxyl pectin 30% 
gelatin gummies pH 2.9; PGDS4, 4% low-methoxyl pectin 30% gelatin gummies pH 2.8; 
PGDS3, 2% high-methoxyl pectin 8% gelatin gummies pH 2.8; PGDS2, 2% low-methoxyl 
pectin 8% gelatin gummies pH 2.85.    
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Figure 3.11. Swelling index studies of pectin-gelatin based delivery systems loaded with 
FOCAXUAE in simulated gastric fluid (SGF pH 1.2). PGDS7, 3% high-methoxyl pectin 15% 
gelatin gummies coated with HPMC (5% wt.) pH 3.55; PGDS6, 3% low-methoxyl pectin 15% 
gelatin gummies coated with HPMC (5% wt.) pH 2.9; PGDS5, 4% high-methoxyl pectin 30% 
gelatin gummies pH 2.9; PGDS4, 4% low-methoxyl pectin 30% gelatin gummies pH 2.8; 
PGDS3, 2% high-methoxyl pectin 8% gelatin gummies pH 2.8; PGDS2, 2% low-methoxyl 
pectin 8% gelatin gummies pH 2.85.   
 
Figure 3.12. Swelling index studies of pectin-gelatin based delivery systems loaded with 
FOCAXUAE in distilled water (DW). PGDS7, 3% high-methoxyl pectin 15% gelatin gummies 
coated with HPMC (5% wt.) pH 3.55; PGDS6, 3% low-methoxyl pectin 15% gelatin gummies 
coated with HPMC (5% wt.) pH 2.9; PGDS5, 4% high-methoxyl pectin 30% gelatin gummies 
pH 2.9; PGDS4, 4% low-methoxyl pectin 30% gelatin gummies pH 2.8; PGDS3, 2% high-
methoxyl pectin 8% gelatin gummies pH 2.8; PGDS2, 2% low-methoxyl pectin 8% gelatin 
gummies pH 2.85.   
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3.3.2.2 Releasing Study 
Despite the formation of a gel due to the presence of gelatin, the absence of divalent 
cations in the media used to prepare the PDGS prevent LMP gummies from forming junctions 
and a network of polymer chains to entrap FOCAXUAE. Thus, making PGDSs formulated with 
LMP incapable of controlling the release of FOCAXUAE, see Figures . LMP is capable of 
forming three dimensional rigid and water insoluble hydrogels through ionic interactions 
between divalent cations (i.e., Ca2+), and the free carboxyl groups of the pectin (Powell, Morris, 
Gidley, & Rees, 1982). PGDS formulations containing HMP were under the potential gelling 
conditions required (i.e., necessary concentration of pectin, pH, concentration of sucrose) during 
preparation. HMPs added gel forming ability was increased at lower pH (SGF, pH 1.2), as 
compared to the pH of SIF (pH 6.8), therefore slowing the release of astaxanthin in SGF. Gel 
formation of HMPs only occur when the pH value is sufficiently low to suppress the electrostatic 
repulsions between charged carboxyl groups (–CO2H or –COOH) resulting in increased hydrogen 
bonding and hydrophobic interactions between the pectin molecules (Löfgren & Hermansson, 2007). 
The same would be the case for LMP if divalent cations were present.  
None of the PGDS gummies tested in SGF dissolution media were able to prevent release 
of FOCAXUAE into the stomach milieu mimicking solution. However, with PGDS7 and 
PGDS6, the acid environment of SGF dissolution media was slower to degrade the HPMC 
coating. The HPMC provides gastric-resistant properties, which resulted in a delayed liberation 
of the incorporated FOCAXUAE (Cole et al., 2002), reported similar finding using HPMC as an 
enteric coating. However, if the FOCAXUAE would have been encapsulated by pectin in the 
PGDS gummies without HPMC, early release may have been slowed or prevented. According to 
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the release study, gels with pectin dissolved slower in SGF than SIF. To mimic the GI tract 
transit times, the gels were only subjected to SGF for 120 minutes, and to SIF for 180 minutes.  
 
Figure 3.13. Release characteristics of pectin-gelatin based delivery systems loaded with 
FOCAXUAE in simulated gastric fluid (SGF pH 1.2). PGDS7, 3% high-methoxyl pectin 15% 
gelatin gummies coated with HPMC (5% wt.) pH 3.55; PGDS6, 3% low-methoxyl pectin 15% 
gelatin gummies coated with HPMC (5% wt.) pH 2.9; PGDS5, 4% high-methoxyl pectin 30% 
gelatin gummies pH 2.9; PGDS4, 4% low-methoxyl pectin 30% gelatin gummies pH 2.8; 
PGDS3, 2% high-methoxyl pectin 8% gelatin gummies pH 2.8; PGDS2, 2% low-methoxyl 
pectin 8% gelatin gummies pH 2.85.   
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Figure 3.14. Release characteristics of pectin-gelatin based delivery systems loaded with 
FOCAXUAE in simulated intestinal fluid (SIF pH 6.8). PGDS7, 3% high-methoxyl pectin 15% 
gelatin gummies coated with HPMC (5% wt.) pH 3.55; PGDS6, 3% low-methoxyl pectin 15% 
gelatin gummies coated with HPMC (5% wt.) pH 2.9; PGDS5, 4% high-methoxyl pectin 30% 
gelatin gummies pH 2.9; PGDS4, 4% low-methoxyl pectin 30% gelatin gummies pH 2.8; 
PGDS3, 2% high-methoxyl pectin 8% gelatin gummies pH 2.8; PGDS2, 2% low-methoxyl 
pectin 8% gelatin gummies pH 2.85.   
3.3.3 Micrographs of pectin-gelatin delivery systems  
FIB-SEM images of the PGDSs revealed some physical attributes to explain the burst 
seen in the release profiles and further explained the releases characteristics observed. For 
instance, the lack of homogeneity and ordered distribution of the FOCAXUAE within the 
PGDS2, PGDS3, PGDS4, and PGDS5 explains the trends seen in the release profiles. Perhaps, 
the lack of favorable interactions occurring within the colloid system during preparations 
resulted in the separating out of the bioactive compounds, coalesced lipid droplets (arrows in 
Figure 3.15A-D), however, with PGDS3 and PGDS5, Figure 3.15B and D, there are fewer 
formless globules seen. With the formulations of PGDS2-5 samples with consistent release 
characteristics among the treatments (n=5) could not be generated. However, with the addition 
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HPMC, better release characteristics were seen and apparent by the structures seen in the 
micrographs below, Figure 3.11. E and F (arrows show double encapsulated FOCAXUAE. 
 
  
  
Figure 3.15. Scanning electron micrograph of cross-section of PGDS sample, after freeze drying 
(350 to 3,500x magnification). PGDS2 (A) - 2% LMP:8% G, pH 2.85 (5%); PGDS3 (B) - 2% 
HMP:8% G pH 2.8 (5%); PGDS4 (C) - 4% LMP:30% G pH 2.8 (8%); (caption cont'd).    
F 
B 
D 
A 
C 
E 
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PGDS5 (D) - 4% HMP:30% G pH 2.9 (8%); PGDS6 (E) - 3% LMP:15% G:5% HPMC pH 2.9 
(10%); PGDS7 (F) - 3% HMP:15% G:5% HPMC pH 2.9 (10%). Shaded arrows in E and D 
indicate double encapsulation. 
Initially, it was expected that LMP would be more compatible with gelatin and would 
form a single-phase system, compared to HMP and gelatin. However, the inability of LMP in 
encapsulating FOCAXUAE and the lack of gel formation proved otherwise. Furthermore, the gel 
forming capabilities of HMP were not affected by the presence of a second or third polymer. 
However, the presence of HPMC did induce the formation of capsules. Studies have reported the 
ability of high concentrations of Na+ and K+ ions induce gelation, regardless of alkali hydroxides 
NaOH and KOH preventing gelation due to demethoxylation (Wehr, Menzies, & Blamey, 2004).  
This explains the inability of LMP to retain a gel in SIF. 
3.3.4 Characterization of the PGDS 
The FOCAXUAE is encapsulated in a double emulsion of pectin and HPMC within the 
gelatin network that appeared heterogeneous in size, PGDS6 and PGDS7, Figure 3.15E and F, 
respectively. However, in the formulation with HMP, Figure 3.15F, there was greater uniformity 
among the size of the capsules. The PGDS without HPMC showed less uniformity, as there were 
FOCAXUAE globules (formless shapes) of FOCAXUAE in cross sections of the freeze-dried 
hydrogels (Figure 3.11A-C) or a small number of FOCAXUAE droplets (Figure 3.15D). The 
SEM images obtained are representative of high encapsulation efficiency, which was 94 ± 1% 
for the three samples.  
Moreover, high-methoxyl pectin had a high encapsulation efficiency (89.2%) and 
contributed to the controlled release of FOCAXUAE in both SIF and SGF with and without 
HPMC. HMP solutions gel because of hydrophobic interactions and hydrogen bonding between 
pectin molecules, while LMP solutions rcquire a sufficient concentration of divalent cations to 
gel. The initial burst release (within the first 15 minutes) is thought to be caused by poorly 
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entrapped FOCAXUAE, weak network formation from highly hydrated and charged carboxylate 
groups, or the FOCAXUAE adsorbed onto the outside of the particles. The very glossy surface 
of the PGDS cubes is because the amount of regular reflection from the surface is high and the 
amount of diffuse reflection is low. In contrast, HPMC capsules have a visually matt surface 
with a greater amount of diffuse reflection, suggestive of a more irregular surface. This may 
imply possible formation of an enteric barrier around the PGDS gummies 
The PGDS (PGDS6 and PGDS7) prepared with HPMC (%5 wt./wt. of final volume) 
resulted in a delay of the burst release of FOCAXUAE, which can be attributed to a film coating 
developing around the delivery system when exposed to a near neutral solution. Release of AX 
from the PGDS matrix was investigated and, in an effort to examine the potential of the pectin-
gelatin gummy confectionary as a lymphatic delivery system release characteristic were 
evaluated.  
Despite the high concentration of sugar, it appears that HPMC particle swelling and 
coalescence may not have been suppressed, as it was in a study by Williams, Ward, Hardy, and 
Melia (2009). Based on data obtained from the swelling study, PGDS with HPMC (5% wt.) had 
extensive swelling for 180 min in SIF, but not in SGF. It is hypothesized that disintegration 
occurred after the three-hour exposure to SIF during the swelling study, as it did for the other 
formulations in both SGF and SIF. That hypothesis is validated by the absence of a burst release 
phenomena when evaluating the release profiles. The                    swelling studies in SGF 
showed that PGDS formulated without a concentration of HPMC to produce an enteric coating 
disintegrated rapidly. It should be noted that an enteric coating may possibly hinder the intestinal 
uptake and absorption of AX in the lymphatic system. Consequently, the gel barrier was not 
capable of tolerating the low pH of the SGF, thus making AX available. Aside from the subtle 
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swelling occurring, in the SGF, you can see that there is less burst of oil release from PGDS6 and 
PGDS7. In all other formulations, there was no gel layer formation on the surface of the PGDS, 
therefore the matrix had immediate release characteristics. Weaker gel layers were formed in 
PGDS2, PGDS3, PGDS4, and PGDS5, as evidenced by the fact that no data could be collected 
from the swelling study. In PGDS formulated without HPMC, the release of FOCAXUAE was 
unavoidable. Looking at the formulations combining gelatin with HMP, there was an associative 
interaction between the two polymers and neither component had an effect on the other. The gel 
strength of PGDS4, PGDS5, PGDS6 and PGDS7 was evidenced by their firmness when 
compressed between the index and thumb fingers and their retained shape (by visual inspection).  
HMP gels when the molecules are hydrated, and subsequently lose some of the water 
(dehydration) due to the presence of co-solutes, i.e., high concentrations of sugar. Dehydration 
causes the pectin molecules to form hydrogen bonds between chains, resulting in a decrease in 
electrostatic forces (decrease in cross-linking by divalent cations). Those hydrogen bonds create 
a network to trap the remaining water and solute molecules. In this case, PGDS2 and PGDS5, 
despite the inability of the pectin to encapsulate the FOCAXUAE, the properties of HPMC 
within the PGDS6 and PGDS7 formulations create the conditions necessary to form a network to 
protect the bioactive compound. The resulting formulation contained a double emulsion.  
3.4 Conclusion 
 A hydrocolloid delivery system, which incorporated the astaxanthin (in flaxseed oil) into 
edible gummies, was designed, developed and tested. The delivery system was tested in 
simulated gastric fluid (SGF) and simulated intestinal fluid (SIF), and performed well. It 
withstood SGF for typical stomach transit times and released the flaxseed oil (solvent) 
containing astaxanthin within normal GI tract times when tested in the simulated intestinal 
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environment. Rapid release of FOCAXUAE from pectin:gelatin:HPMC delivery systems was 
prevented by the presence of the cellulose derivative HPMC. In addition to not encapsulating 
FOCAXUAE, the other formulations were not capable of maintaining their gel structure in the 
SGF media, purporting that the necessary conditions to sustain such gelation were not met. The 
cation concentration in either the SGF or the SIF media were not in concentrations great enough 
to elicit an ionotropic gelation mechanism with the LMP. However, one must consider the that 
de-esterified LMP is unable to form gels without the presence of calcium. Therefore, no 
sufficient gel structures were formed at a low pH. With an increase in the pH (pH 6.8), which 
decreases the amount of a divalent cations (Ca+) needed for gelation, gelling was observed in 
SIF, which contained calcium chloride. LMP is deesterified in alkaline environments, thus 
decreasing the requirement of a divalent cation for gelation (Garnier, Axelos, & Thibault, 1993). 
The results of this study showed that, potentially, the delivery system that was designed and 
developed using HMP or LMP, gelatin, and HPMC can be used for the controlled release of 
flaxseed oil containing astaxanthin. 
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CHAPTER 4 ASTAXANTHIN: CHEMOTHERAPEUTIC PROPERTIES 
4.1 Introduction 
The dietary intake of carotenoids derived from the marine environments provide numerous 
health beneficial effects such as antioxidant, antimicrobial, anti-inflammatory, and anti-cancer 
activities (Boominathan & Mahesh, 2015). Astaxanthin (AX), a ketocarotenoid, found 
throughout marine organisms, most notably particular interest to the crustacean species of 
Louisiana (shrimp, Litopenaeus spp. and red swamp crawfish, Procambarus clarkii). Beneficial 
properties of astaxanthin include; reducing the risk of heart disease, inflammation, and oxidative 
stress, in addition to a plethora of anti-cancer roles (Kowshik et al., 2014; Kurihara, Koda, 
Asami, Kiso, & Tanaka, 2002; Palozza et al., 2009; L. Zhang & Wang, 2015). The consumption 
of dietary carotenoids is reported to contribute to the inverse relationship between dietary intake 
and the risk of major clinical diseases, such as cancer. 
Cancer has a global impact on people of all social classes. Breast cancer, the primary cause 
of cancer deaths in women, can be classified into estrogen receptors (ERs) +, human epithelial 
growth factor receptor 2 (HER2) +, and triple-negative breast cancer (TNBC) subtypes (Qu et 
al., 2014; T. Yoshida et al., 2014). Treatment of TNBC is the toughest obstacle for researchers 
because of its invasive and aggressive nature, as well there be fewer targeted medications. This 
metastatic characteristic of TNBC is the reason for it having the lowest survival rate of any other 
subtype of breast cancer. Very few drugs have been approved for the treatment of TNBC. 
Treatments for metastatic TNBC are centered around improving the quality of life through 
reduction of the cancer-related symptoms, as opposed to providing a cure, the primary goal of 
treatment for patients with localized breast cancers (Zeichner, Terawaki, & Gogineni, 2016).  
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Over the past years, carotenoids have been delivered to cells in culture incorporated in 
liposomes, water-miscible beadlets or mixed micelles (O'Sullivan, Woods, & O'Brien, 2004). 
Additionally, organic solvents have been used as delivery vehicles for carotenoids, despite 
classic difficulties of insolubility, instability, and cytotoxicity being related to solvent use. 
In this study, the effect of ultrasound assisted extracted astaxanthin in flaxseed oil 
(FOCAXUAE) from crawfish processing byproducts (CB) delivered to cells in culture on cell 
density and the cell propensity of MDA-MB-231 cells, a triple-negative breast cancer cell line, to 
undergo an epithelial-mesenchymal transition (EMT), was investigated. 
4.2 Materials & Methods 
4.2.1 Emulsions with and without astaxanthin preparation for cell treatment 
Astaxanthin was extracted by the method described above in section 2.2.3.2. of Chapter 2, 
with some modification. Ethanol (200 g) used for extraction of CB (25 g). Three hundred grams 
of ethanol was used to extract astaxanthin from a total of 100 g of CB; this includes washing and 
filtration procedures. Astaxanthin content in the ethanol extracts was determined based on the 
equation adopted from (Takeungwongtrakul & Benjakul, 2016). For determination of astaxanthin 
content, 5 g of FO was added to a 100 ml aliquot of the ethanol with astaxanthin extract.  
Four amphiphilic surfactants, tween 20 (T20), tween 80 (T80), triton X (TX), and 
sunflower lecithin (SL), were used to emulsify the oil-in-water (flaxseed oil in DMEM) 
formulations to deliver astaxanthin extracted CB in vitro. Surfactant was mixed with DMEM to 
prepare a 1:100, 1:1000 or 0.5:1000 dilutions. The mixtures were sonicated for 60 s using an 
ultrasonic processor (Model CPX 500, Cole Palmer Instruments, Vernon Hills, IL, USA) with a 
2mm stepped microtip probe threaded to the 10 mm probe of an ultrasonic booster horn fitted to 
an ultrasound converter for producing sonic waves at a frequency of 20 kHz electrical energy.  
 113 
Following surfactant selection, emulsions were prepared by adding oil (100mg, 10%w/v) to 
1mL of DMEM. Then 25 mg of emulsifier were added (2.5% w/v). Then, the solution was 
vortexed at 3000 rpm for 1 min before further emulsification using an ultrasonic processor 
(Model CPX 500, Cole Palmer Instruments, Vernon Hills, IL, USA) with a 2mm stepped 
microtip probe. This microtip probe was threaded to a 10mm horn fitted on an ultrasonic 
converter, for producing sonic waves at a frequency of 20 kHz. Emulsions were prepared in a 5 
ml amber Eppendorf to prevent photooxidation. 
4.2.2 Emulsion Stability 
Emulsions prepared by adding oil (100mg, 10%w/v) to 1mL of DMEM, then adding 25 mg 
of emulsifier (2.5% w/v). This solution was vortexed at 3000 rpm for 1 min before further 
emulsification using an ultrasonic processor (Model CPX 500, Cole Palmer Instruments, Vernon 
Hills, IL, USA) with 13 mm probe connected to an ultrasound converter for producing sonic 
waves at 20% power of 20 kHz electrical energy. Similar to the parameters used for preparing 
emulsions for treatments. To measure turbidity at 500 nm 10ul of emulsion was added to 3 mL of 
0.1% sodium dodecyl sulfate (SDS, a 300-dilution factor) in cuvettes immediately after emulsion 
preparation. Other data not shown.  
Following surfactant selection, emulsions were prepared by adding oil (100mg, 10%w/v) to 
1mL of DMEM. Then 25 mg of emulsifier were added (2.5% w/v). Then, the solution was 
vortexed at 3000 rpm for 1 min before further emulsification using an ultrasonic processor 
(Model CPX 500, Cole Palmer Instruments, Vernon Hills, IL, USA) with a 2mm stepped 
microtip probe. This microtip probe was threaded to a 10mm horn fitted on an ultrasonic 
converter, for producing sonic waves at a frequency of 20 kHz. Emulsion were prepared in a 5 
ml amber Eppendorf to prevent photooxidation. 
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4.2.2 Cell culture 
The human breast cancer cell, MDA-MB-231 (passages 30–32) was cultivated in 100-mm-
diameter tissue culture flask. Cells were maintained in 5% CO2 at 37⁰C and cultured in 
Dulbecco’s modified Eagle’s medium (DMEM; Gibco BRL, Grant Island, NY) supplemented 
with 10% Hyclone Cosmic Calf Serum (HyClone Laboratories, Utah), 50 ng/mL insulin (Sigma-
Aldrich, St. Louis, MO, USA), and 1% MEMAA, NEAA, sodium pyruvate and antibiotic-
antimycotic (Gibco, Dublin, Ireland). For experiments, MDA-MB-231 cells were seeded at a low 
density (5 × 103 cells/well) into a 96-well plate. 
4.2.3 MDA-MB-231 cell density 
To examine the anticancer effects of astaxanthin emulsions (AXE, 3µM, 5µM, and 7µM) 
on MDA-MB-231 cells, a 96-well plate was incubated for 2 days, before being treated. 
Following incubation period, AXE was carefully removed from wells containing cells. Cells 
were stained with 33% crystal violet, 20 µL per well, for 15 minutes on a rocker then washed 
and allowed to dry (2 hours). After drying, cells were either assessed for morphological 
characteristics or stains eluted for relative cell viability (RCV) per section 4.2.3. The cells were 
imaged using an inverted fluorescence microscope (Nikon Eclipse Ti2), and NIS Elements 
Advanced Research Microscope Imaging Software (NIS Elements AR, Nikon). 
4.2.4 In vitro assessment of astaxanthin exposure from AX emulsions on MDA-MB-231 
cells for cell viability 
 
The viability of the MDA-MB-231 and cellular contact with AXE was evaluated using 
absorbance measurements. The absorbance indicated relative cell viability (RCV) in regards to 
the relative number of total cells (fixed cells with uncompromised membranes to retain the 
crystal violet dye) in a one well compared to another. The emulsions diluted with DMEM was 
carefully removed from cell monolayers, then stained with crystal violet was added to the wells 
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containing cell monolayers and placed on a rocker for 15 minutes. Subsequently, the plates were 
rinsed of the stain with water and allowed to dry (2 hrs) RCV was evaluated numerically by 
measuring the optical density (absorbance at 570 nm) with the cell imaging multi-mode plate 
reader Cytation™ 5 (Biotek, Winooski, VT). RCV was calculated based on the equation 4.1:  -'$NM#*'	('$$	*#NO#$#M+	 = 	 (C<2:C42	78	6:2C62=	1299A	CtA7:tCB;2ut9CBv)(C<2:C42	78	;7B6:79	1299A	CtA7:tCB;2ut9CBv) × 100         (Eq. 4.1) 
4.2.5 Statistical Analysis 
All data were analyzed with GraphPad Prism 4.0 software (GraphPad Software, Inc.; San 
Diego, CA, USA). The RCV was evaluated by one sample t-test and Wilcoxon test at a 
significance level of 0.05 and plotted by GraphPad Prism. 
4.3 Results & Discussion 
The genomic characteristics and nature of TNBC cells make them difficult to target and 
treat. The utilization of a natural anti-cancer agent, like astaxanthin, is important for improving 
upon the adjuvant treatments available for TNBC patients. This not only reduces the side effects 
of systemic therapies routinely used, it also improves upon the quality of life during recovery. 
Over the past years, carotenoids have been delivered to cells in culture incorporated in 
liposomes, water-miscible beadlets or mixed micelles (O'Sullivan et al., 2004). Additionally, 
organic solvents have been used as delivery vehicles for carotenoids, despite classic difficulties 
of insolubility, instability, and cytotoxicity being related to solvent use.  
During preliminary tests, a visual confluency estimate was used to assess the effects of the 
four surfactants to emulsify DMEM and flaxseed oil on the viability MDA-MB-231 cells. 
Multiple variations in the concentration of surfactants (i.e., high, medium, and low) SL, T20, 
T80, and TX were assessed. Sunflower lecithin (SL) was found to show minimal deleterious 
effects on the viability of MDA-MB-231 cells, as seen in Figure 4.1. Various concentrations 
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were tested to determine the ideal amount of surfactant to achieve the optimal response from the 
MDA-MB-231 cells as it relates to viability. Visually inspections show that T20 and TX have a 
greater anti-proliferative or apoptotic effect in terms of cell density than do T80 and LC on 
MDA-MB-231 cells. Some results not pictured. 
      DMEM           SL:FO     T20:FO                T80:FO  TX:FO 
 
 
 
Figure 4.1. Visual confluency estimation to surfactant and optimization. Microscopy using 
a Nikon Eclipse Ti2 inverted fluorescence microscope at 2x magnification.  
Once the dosages optimize with a suitable concentration of surfactant to use in delivering 
AX in vitro, a closer assessment of the effects of surfactant/emulsifier on the relative cell number 
(%, RCV) of MDA-MB-231 cells was assessed before proceeding with treatments. Sunflower 
lecithin showed a more representative RCV (79.37±0.87) than the other surfactants, (T20 
(8.6±2.51), T80 (25.04±3.00), and TX (17.11±3.00)), shown in Figure 4.2. Also, considering the 
ultimate goal of the study is to utilize natural rather than synthetic compounds to attenuate the 
deleterious effects of TNBC and the adjuvant therapies available. 
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Figure 4.2. MDA-MB-231 % cell viability in different surfactants. Means±SEM of 
triplicate determinations. **p<0.01, ***p<0.001. DMEM = Dulbecco’s modified Eagle’s 
medium. SL = lecithin. T20 = Tween 20. T80 = Tween 80. TX = Triton X. 
AX emulsions (AXE) were prepared in DMEM with 10% sunflower lecithin (SL) at 
concentrations of 0.0025:0.005% to 0.1:0.2% (LD:AXE, wt:wt). Controls prepared at same 
concentrations as LD:AXE, using flaxseed oil without AX. MDA-MB-231 cell line was seeded 
at 5 × 103 cells/well in 96-well plates and incubated at 37 °C for 24 hours. Cells were then 
treated with 100 µL/well LD:E or LD:AXE. LD:AXE treated cells (image b, 1-9) displayed a 
mesenchymal-to-epithelial transition (MET) compared to control treated cells (image a, C and 
E), which suggests a less metastatic and aggressive phenotype. LD:AXE treatments resulted in a 
decrease in cell number in a somewhat dose-dependent (3 µM, 5 µM, and 7 µM AX) manner, 
seen by RCV decreasing by 46.31%, 42.2%, and 55.51%, respectively, from the normalized 
value (Figure 4.3).  
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Figure 4.3. MDA-MB-231 viability of treated cells. Means ± SEM of triplicate 
determinations. **p<0.01, ***p<0.001. LC = lecithin control. 3 µM = LC with 3 µM 
astaxanthin. 3 µM = LC with 5 µM astaxanthin. 3 µM = LC with 7 µM astaxanthin. 
The morphology of astaxanthin treated cells compared to untreated cells showed a 
decreased number of cells resembling a mesenchymal-like phenotype (Figure 4.4. b) 1-9). This is 
suggestive of a mesenchymal-to-epithelial transition (MET), or reversal of EMT. EMT has been 
reported to be the cause of the invasive, metastatic, and multi-drug resistant nature of cancer 
cells (Chaffer, San Juan, Lim, & Weinberg, 2016; Du & Shim, 2016; Little et al., 2016; Milano, 
Muthuswamy, & Asthagiri, 2016; Pastushenko & Blanpain, 2019). In this study, LC:FO alone 
did not significantly affect MDA-MB-231 cell viability or MET. Thus, indicating the possibility 
that neither LC or FO possess any cytotoxic or genotoxic activity in the levels used. 
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Figure 4.4. Evaluation of astaxanthin on the morphology of MDA-MB-231 triple-negative 
breast cancer cell line in vitro by darkfield microscopy. Microscopy using a Nikon Eclipse Ti2 
inverted fluorescence microscope. 
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Microscopy revealed (Figure 4.4) MDA-MB-231 cells displayed (A) epithelial and (B) 
mesenchymal-like, spindle-shaped cells. (C, E) Control MDA-MB-231 cells in DMEM and (D, 
F) treated MDA-MB-231 cells by brightfield microscopy. MDA-MB-231 cells grew as sheet-like 
monolayers (indicated by arrow) of tightly packed colonies. (Image b) MDA-MB-231 cells in 
flaxseed oil DMEM emulsion with astaxanthin (AX) increasing in concentration appears to 
increase cell to cell interactions (4-9), compared to the loss of cell to cell interaction at 7 µM 
treatments (1-3). MDA-MB-231 cells treated with AX at 3µM, 5µM, and 7µM concentrations 
exhibit a reduction in cells displaying mesenchymal-like morphology. MDA-MB-231 cells 
treated with 5 µM astaxanthin had an increase in cell population (4), compared to those treated 
with 7 µM (1-3) having small rounded cells with a globular appearance (possibly dead with 
debris). Numerous MDA-MB-231 cells are egg-shaped and flattened with characteristic 
morphologies resembling epithelial cells. Some cells show filopodia (8). Different concentrations 
of AX exert varying degrees of cell to cell adhesion (4,7) and dissemination (1). More 
importantly, spindle-like cells with mesenchymal morphology appear to be reduced in a dose 
dependent manner.  
In addition to cells gaining motility and invasiveness when they undergo an EMT, they also 
develop novel interactions with the microenvironment. Such interactions lead to the migration of 
cancer cells from one site to the next. 
4.4 Conclusion 
The studies reported here demonstrate that AX exerts anticancer effects on MDA-MB-231 
cells in vitro with respect to cell viability and morphology. The RCV of MDA-MB-231 was 
reduced. It can be seen that the incorporation of SL as a vehicle for administration of the 
bioactive compound AX, has a significant effect on the growth or phenotypic changes to MDA-
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MB-231 cells based on the RCV (Figure 4.3). The same can be said about flaxseed oil. 
Additionally, MET was suggested to be induced in vitro, thereby decreasing the TNBC 
metastasis and possibly prolonging survival. However, an in vivo analysis would have to be 
performed before such correlation can be accepted. These results provide insight on the potential 
application of crawfish derived astaxanthin, as a potential therapeutic agent in TNBC treatment. 
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CHAPTER 5 CONCLUSION 
Astaxanthin (AX) was extracted from crustacean processing byproducts, shrimp 
processing byproducts (SB) and crawfish processing byproducts (CB), using flaxseed oil. Higher 
extraction yields of AX is achieved using CB. Extraction of AX from CB in a continuous 
ultrasound assisted extraction (UAE) system yielded even greater recoveries than UAE of AX 
from SB and the conventional extraction method from SB and CB. Effects of conventional 
extraction and UAE of AX from SB and CB on the oxidation and stability of the flaxseed oil 
were evaluated. The UAE of AX extracted from CB had a greater antioxidant capacity, than 
other extracts tested. UAE was effective for increasing the recovery of AX from CB and 
preventing a loss in the quality of the flaxseed oil used as an extraction solvent. The UAE 
method was also effective for concentrating AX to be used in the design and development of a 
delivery system. The delivery system, composed of three polymers, hydroxypropyl 
methylcellulose (HPMC), gelatin (G), and pectin (P), was used to encapsulate flaxseed oil 
containing AX (FOAX). The polymeric delivery system was capable of delaying the release of 
the FOAX extracted CB in simulated gastrointestinal tract fluids by several mechanisms afforded 
by the polymers (HPMC as an enteric coating, G gelling properties to slow release, and P gelling 
properties in ionic solutions to slow release). Additionally, AX extracted from CB showed 
anticancer properties against a triple negative breast cancer (TNBC), MDA-MB-231 cells in 
vitro. Exposure of the MDA-MB-231 cells to AX altered cell morphology. A greater number of 
cells exposed to AX reversed their epithelial-to-mesenchymal transition (EMT), representing a 
less aggressive phenotype of TNBC MDA-MB-231. Nonetheless, an in vivo analysis needs to be 
performed prior to a correlation between a mesenchymal-to-epithelial transition (MET) and 
decreased metastasis with increased life expectancy in human subjects. 
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